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Arpin, Carolynn Chin (Ph.D., Chemistry) 
Cross-Metathesis of Electron-Deficient Polyenes and Studies Toward the Total 
Synthesis of Arenolide 
Thesis directed by Professor Tarek Sammakia 
 
 The selectivity of the cross-metathesis reaction between electron-deficient 
polyenes and a general terminal alkene by use of different metathesis catalysts is 
presented.  The reaction was found to be the most efficient when applied between a 
monoene or triene and the terminal alkene, providing the desired product in good to 
excellent yields.  The selectivity is attributed to the reactivity of the terminal alkene 
of the triene which is furthest removed from the electron-withdrawing aldehyde or 
ester, rendering it the only alkene capable of reacting with the catalyst.  Diene and 
tetraene substrates were not good partners in this reaction due to a lack of 
differentiation of the alkenes. 
 Different approaches toward the total synthesis of arenolide, a 14-membered 
macrolide with unclear stereochemical assignment and bioactivity, are also discussed.  
The first approach utilizes a 1,5-anti aldol reaction that was found to lack 
diastereoselectivity when applied to the total synthesis.  The second-generation 
approach focuses on alternative methods to produce the 1,5-anti relationship between 
the alcohols at C9 and C13 with the exo-methylene group at C11.  All studies include 
the use of a key intramolecular vinylogous aldol macrocyclization developed in the 
Sammakia lab, which was shown to be effective on a model precursor very similar to 
that of arenolide.  Efforts are underway to complete the total synthesis of arenolide. 
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Chapter 1  
Cross-Metathesis of Electron-Deficient Polyenes 
 
1.1 Olefin Metathesis Background 
 
Olefin metathesis is defined as the exchange of alkylidene moieties between 
alkenes, and with the advent of catalysts with broad substrate scope and high 
functional group tolerance, it has become a widely used and powerful technique for 
the formation of carbon-carbon double-bonds (Scheme 1.1).
1
  
This method has had broad application in both academic and industrial settings, 
primarily because of the powerful bond forming opportunity it provides. In addition, 
its utilization is convenient in that it requires no additional reagents other than the 
catalytic amount of a metal complex, and in most cases the only by-product of the 
reaction is a volatile olefin such as ethylene.
2
  Olefin metathesis was first introduced 
in the 1950s primarily as an industrial polymerization technique, the main application 
of which was in catalytic ring-opening metathesis polymerization reactions (ROMP).  
These reactions are thermodynamically favored, especially for strained ring systems, 
and they have seen extensive exploitation in the manufacture of specialty polymers.
3
    
The next key development in the field was that of catalytic ring-closing metathesis 
reactions (RCM).  In this case, the forward process is entropically driven since the 
reaction begins with one molecule and provides two molecules as products. The 
utility of this process lies in its broad substrate scope which the synthesis of small, 
medium, or large rings from acyclic precursors.
2,4
  Finally, olefin cross-metathesis 
2 
 
reactions (CM) were the most recent to be studied and developed.  CM reactions are 
of particular significance because they serve as convenient routes to functionalized 
and higher olefins from simple alkene precursors.  Other synthetically useful 
reactions involving olefin metathesis include acyclic diene metathesis 
polymerization,
3
 ene-yne metathesis,
5
 and many other tandem processes: ring-
opening followed by cross-metathesis,
6
 ring-opening—ring-closing metathesis 
reactions,
7
 and ene-yne RCM followed by CM reactions are just a few examples.
5
  
Scheme 1.1.  General Metathesis Schematic and Common Metathesis Reactions. 
 
Early olefin metathesis processes were characterized by multi-component 
catalyst systems; typically transition metal salts in combination with main group 
alkylating agents.
8
  These systems suffered from limited efficacy, however, due to 
their incompatibility with common functional groups and poorly defined nature which 
presented difficulties with initiation and control.  With the late 1980s and early 1990s 
came the rapid development of new olefin metathesis catalysts, the most notable of 
which is the Shrock molybdenum catalyst 1, shown in Figure 1.1.
9
  Unfortunately, 
this catalyst and others based on the early transition metals are extremely sensitive to 
oxygen and moisture due to the high oxophilicity of the metal centers.
8
  As a result, 
3 
 
catalyst-design began to focus on late transition metals, specifically Ru-derived 
catalysts, which were known to react preferentially with olefins over alcohols, acids, 
and other common functional groups.  Although their activity is usually lower than 1, 
the increased functional group tolerance and ease of handling rendered catalysts 2, 3 
and 4 significantly more practical (Figure 1.1).
4,10-13
  With the development of these 
well-defined ruthenium catalysts, the installation of structural elements within 
complex natural products, and the synthesis of simpler substrates for further synthetic 
transformations can be accomplished. 
Figure 1.1.  Commonly Used Olefin Metathesis Catalysts. 
 
With these new, well-defined catalysts came a dramatic increase in the 
application of olefin metathesis to complex synthesis, and as a result further detailed 
experimental and theoretical studies have been carried out to elucidate the mechanism 
of action of catalysts 2, 3, and 4.  The accepted mechanism, first proposed by 
Chauvin, consists of the formation of a metallacyclobutane intermediate, which is 
formed by a formal [2+2] reaction between the alkene and the carbenoid, followed by 
a formal retro-[2+2] to release the product and regenerate a carbene.  In the case of 
4 
 
the Grubbs catalysts, dissociation of a phosphine ligand precedes olefin complexation 
and formation of the metallacyclobutane intermediate.  This intermediate then 
undergoes a formal retro-[2+2] to give the olefin product and a new metallocarbene 
as shown in Figure 1.2.
14
  The resulting metallocarbene then reenters the catalytic 
cycle by binding to another olefin substrate. 
Figure 1.2.  Accepted Olefin Metathesis Cycle. 
 
Initial mechanistic studies by Grubbs did not distinguish between an 
associative and dissociative ligand exchange of the phosphine with olefinic substrate, 
which is critical since this step forms a coordinatively unsaturated intermediate with 
greater propensity for binding of the olefin and entry into the catalytic cycle.  An 
associative exchange was originally proposed on the basis of a preference for an 18-
electron intermediate over a 14-electron-intermediate.  However, most recent 
investigations have implicated a dissociative ligand exchange followed by the 
formation of a metallacyclobutane intermediate that collapses to give the olefin 
product (Scheme 1.2).
10
 
 
5 
 
Scheme 1.2.  Dissociative Ligand Exchange Mechanism that Allows Entry of 
Catalyst into the Catalytic Cycle. 
 
 
1.2  Selectivity in Olefin Cross-Metathesis 
 
Until recently, olefin cross-metathesis (CM) has been an underrepresented 
area of olefin metathesis when compared to ROMP and RCM reactions. This has 
primarily been due to several factors: first, in the absence of a strong enthalpic 
driving force (such as ring-strain release in ROMP) or the entropic advantage of 
intramolecular reactions (such as RCM), the reaction mixture will be under 
equilibrium and thermodynamic control, which might or might not favor products.  
Second, there can be low selectivity for the CM product versus the two possible 
homodimer products, and third, there can be poor E versus Z selectivity in the newly 
formed olefin (Scheme 1.3).
15
   
Scheme 1.3.  Possible CM Reaction Products. 
 
Recently, however, the rapidly expanding body of CM literature and analyses 
has provided the foundation for an empirical model for product-selective cross-
metathesis.  According to Grubbs et al., a straightforward and practical ordering or 
6 
 
categorization of olefin reactivity is first required in order to predict the selectivity for 
a CM product.
15
  The most convenient way to determine this ordering is to rank olefin 
reactivity as a function of ability to homodimerize relative to other olefins, along with 
the subsequent reactivity of their homodimers.  This analysis leads to a general model 
that consists of four distinct olefin types and can be used to predict both selective and 
non-selective CM reactions (Figure 1.3). 
Figure 1.3.  Olefin Categorization and Rules for Selectivity in CM Reactions. 
 
 In general, a reactivity gradient exists from the most active type (Type I 
olefin) to least active type (Type IV), with sterically unhindered, electron-rich olefins 
categorized as Type I and increasingly sterically hindered and/or electron-deficient 
olefins falling into Types II through IV.  Note that this activity is catalyst-dependent.  
What may be classified as a Type I olefin with a more reactive catalyst could be a 
Type II or III olefin in regards to a less reactive catalyst.  The reactivity of an olefin 
with a given catalyst also determines the role of secondary metathesis events, which 
can be described as subsequent reactions of a product olefin with the propagating 
catalyst.  Two factors, then, are key to a selective CM reaction, the first being the 
ability to minimize the number of undesired side products (such as homodimers of the 
original olefins) by avoiding their initial formation or rendering their formation 
reversible through secondary metathesis events.  The second issue is the prevention of 
7 
 
the desired cross-product from being redistributed into a statistical product mixture of 
products by secondary metathesis events.
15
 
 When two Type I olefins are paired in a CM reaction, the rates of 
homodimerization and cross-product formation are similar, and the reactivities of the 
homodimers and cross-products toward secondary metathesis events can be high.  In 
these reactions, the desired cross-product will be formed at a rate comparable to the 
homodimers, and equilibration of the cross-products with the various homodimers 
through secondary methathesis reactions will result in a statistical product mixture.  
To avoid statistical product distributions, one can design selective CM reactions by 
using olefins from two different types whose rates of dimerization are significantly 
different and/or slower than CM product formation.  This improved cross-product 
selectivity could, however, be accompanied by poor stereoselectivity due to the 
inability of the cross-product to readily undergo cis/trans isomerization via secondary 
metathesis processes.  Nonetheless, many surveys and investigations have shown that 
the use of this method as a starting point for the design of potentially selective CM 
reactions is general and provides reproducible results.
15
 
 
1.3 Polyene Metathesis in Natural Products Synthesis 
 
While olefin metathesis has seen extensive use in the total synthesis of natural 
products, syntheses involving metathesis reactions with polyenes are more limited.  
As stated previously, this is due to chemo- and diastereoselectivity issues 
accompanied by lack of selectivity in regards to the geometry of the newly formed 
8 
 
olefin.  Still, there are several daring and successful examples of the use of polyene 
metathesis reactions in the context of total synthesis. 
Meyers and coworker’s synthesis of (‒)-griseoviridin is one such daring use of 
metathesis of a polyolefinic substrate.
16
  Griseoviridin is part of a family of 
streptogramin antibiotics, and when combined with certain macrocyclic depsipeptides 
they exhibit strong synergism with respect to their activity toward Gram-positive 
bacteria.  The group’s synthesis utilizes a key late-stage ring-closing metathesis 
reaction of a seco-triene (5, Scheme 1.4).  Subsequent deprotection of the cyclized 
lactam (6) provided the target in a total of 24 linear steps from (S)-malic acid. 
Scheme 1.4.  Meyers' Late-Stage RCM in the Total Synthesis of Griseoviridin. 
 
 Although the key RCM reaction only occurs in a reproducible 37-43% yield, 
no other metathesis products were formed in the reaction, and no alkene 
isomerization was observed.  It is somewhat surprising that the reaction is very 
selective for the terminal olefins when the C21-C22 olefin could also be classified as 
Type I; steric constraints likely prevented metathesis events at this site. 
9 
 
 A similar key RCM reaction of an acyclic triene was utilized in Nolan and co-
workers’ syntheses of sanglifehrin macrolide analogues.17  Sanglifehrin A is a potent 
immunosuppressant isolated from Streptomyces flaveolus in 1995 by scientists at 
Novartis.  Unlike that in Meyers’ synthesis of (‒)-griseoviridin, Nolan’s key reaction 
mainly produced the internal metathesis products (8 and 9) upon use of catalyst 3 on 
substrate 7 (Scheme 1.5).  Only ~10% of this crude mixture consisted of the desired 
dienyl macrolide.  However, the group was able to obtain solely the desired products 
10 and 11, wherein metathesis takes place between the terminal olefins, by simply 
switching to catalyst 2.  Also unlike Meyers, Nolan and co-workers isolated some of 
the E,Z-diene isomer, although it was in a small amount (<5%) when using either 
catalyst.  The authors propose a plausible explanation for the switch in olefin 
metathesis selectivity in that the more reactive catalyst 3 offsets the steric limitations 
and is able to react with the more electron-rich internal olefin of the diene.  The less 
reactive catalyst cannot overcome the steric constraints and is therefore limited to 
react with the terminal olefin of the diene. 
10 
 
Scheme 1.5.  Nolan's RCM Reaction in the Syntheses of Sanglifehrin Analogues. 
 
 A final example of yet another selective RCM reaction of an acyclic triene is 
in Danishefsky’s syntheses of radicicol and monocillin I, macrolides isolated from 
Monocillin nordinii that exhibit a variety of antifungal and antibiotic properties.
18
  As 
shown in Scheme 1.6, the macrolide core is formed via selective metathesis at the 
terminal olefins of 12 with Grubbs’ second-generation catalyst (Grubbs II), 3, 
although in this instance the selectivity is not so surprising since the olefin proximal 
to the dithiane is almost certainly too deactivated to participate in the metathesis 
event. 
11 
 
Scheme 1.6.  RCM Reaction and Endgame of Danishefsky's Syntheses of Monocillin 
I and Radicicol. 
 
 Danishefsky reports that the use of Grubbs’ first-generation catalyst (Grubbs 
I), 2, resulted in only trace amounts of the desired product, requiring the increased 
reactivity of Grubbs’ second-generation catalyst.  After removal of the dithiane and 
silyl ethers, monocillin I was obtained, and chlorination via SO2Cl2 provided radicicol 
with a longest linear sequence of 14 steps.  This efficient synthesis enabled the 
production of ample amounts of these natural products and their analogues for use in 
a comprehensive Hsp90-directed drug discovery program. 
 Shair and co-workers accomplished a very elegant synthesis of (‒)-
longithorone A, a cytotoxic marine natural product, in 2002 wherein they utilized two 
difficult ring-closing ene-yne metathesis reactions with two complex polyenes.
19
  The 
key biomimetic transformations of their synthesis consist of an intermolecular Diels-
Alder reaction between two fragments, both formed via a similar ring-closing ene-yne 
metathesis reaction, followed by an intramolecular trans-annular Diels-Alder reaction.  
12 
 
Both ring-closing ene-yne metathesis reactions also produce atropisomers, adding 
another facet of difficulty to the reactions (Scheme 1.7). 
Scheme 1.7.  RCM Reactions in Shair's Synthesis of Longithorone A. 
 
 In forming 14, an atropdiastereoselectivity of >20:1 was determined based on 
nOe analysis and after deprotection of the silyl ether a 42% yield was obtained over 
two steps.  In the production of 15, only a 2.8:1 atropdiastereoselectivity was found, 
along with a 3.9:1 mixture of E/Z isomers at the newly formed internal olefin.  The 
selectivity in both reactions is impressive given the other olefins in each substrate and 
also in that only the 1,3-disubstituted diene scaffold was formed in both products.  
While it is likely that the other trisubstituted olefins in both starting materials are too 
sterically-hindered to participate in metathesis events, the efficiency in forming both 
products is still notable. 
 Another use of an ene-yne RCM reaction with a polyolefinic substrate is that 
of Martin et al.’s synthesis of (+)-epi-8-xanthatin; however, their application also 
13 
 
includes a tandem CM reaction.
20
  (+)-epi-8-Xanthatin is a sesquiterpene lactone that 
displays antimalarial activity, and has recently been shown to inhibit the in vitro 
proliferation of several cultured human tumor cell lines.  Their synthesis culminates 
with a tandem ene-yne RCM/CM reaction with substrate 16 and methyl vinyl ketone 
(Scheme 1.8) and gives the target compound in a longest linear sequence of 14 steps 
with an overall yield of 5.5%. 
Scheme 1.8.  Martin's Tandem RCM/CM Reaction in the Total Synthsis of epi-8-
Xanthatin. 
 
 The selectivity of Martin’s reaction is impressive since not only is the starting 
material a polyene, but methyl vinyl ketone (MVK) is also present in the reaction 
mixture.  Apparently the intramolecular ene-yne RCM reaction is preferred over the 
possible intermolecular reaction of the terminal olefin in 16 and MVK.  All in all, the 
use of this tandem ene-yne RCM/CM reaction was quite intrepid, and its success is 
commendable.   
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While there are several examples of complex ring-closing metathesis reactions 
involving polyenes in total synthesis, there are even fewer that strictly involve 
selective cross-metathesis.  Only after performing a thorough study (discussed later in 
this chapter) of the CM between (2Z,4E)-dienyl esters and other complex terminal 
olefins were Curran and co-workers able to utilize a metathesis reaction in their 
synthesis of (‒)-dictyostatin and its analogues.21  Their route allows for the 
preparation of both epimers of 19, shown in Scheme 1.9, in only six steps on a 
multigram scale via CM.  This piece was one of three key fragments that enabled the 
streamlined synthesis of several new dictyostatin analogues.
22
  
Scheme 1.9.  Curran's Polyene CM Reaction in the Synthesis of Dictyostatin. 
 
In the event, Curran and co-workers used 18, a fluorous derivative of the 
Hoveyda-Grubbs catalyst, as the metathesis catalyst in order to separate the catalyst 
upon reaction work-up via fluorous solid-phase extraction (Scheme 1.9).  They were 
then able to reuse the catalyst with little decrease in activity in two subsequent cycles.  
In total, their initial amount of 1.3 g of catalyst 18 was used to metathesize 33.5 g of 
17 into 24.2 g of product 19 as a single stereoisomer (59% overall yield).  The 
reaction strictly provided the product with 2Z- and 4E-olefin geometries, a 
characteristic that was necessary to carry on the substrate in their total synthesis. 
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Another application of polyene CM was demonstrated in one of the key 
synthetic steps in the total synthesis of the oxopolyene macrolide, RK-397, by 
previous members of our group, Mark Mitton-Fry and Aaron Cullen.
23
  This 
stereochemically complex natural product was isolated in 1993 from a strain of soil 
bacteria and was shown to possess antifungal, antitumor, and antibacterial activities.
24
 
Upon completion of the synthesis of the polyol portion of this target (20), a risky CM 
reaction between the terminal alkene of the polyol fragment and a conjugated triene 
aldehyde piece (21) was studied. 
Scheme 1.10.  Key Polyene CM Reaction in the Total Synthesis of RK-397. 
 
This reaction with catalyst 2 (Grubbs I) was executed to give 22 in an 
excellent yield of 72% and moderate E/Z selectivity of 4:1 (Scheme 1.10).  No other 
metathesis products were isolated from the crude reaction mixture, indicating that 
only the terminal olefin of the trienal was sufficiently active to react.  The two olefins 
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proximal to the aldehyde were most likely too deactivated to participate in the CM 
reaction. 
Finally, a similarly risky CM reaction was also utilized in our group’s 
synthesis of another oxopolyene macrolide, dermostatin A.
25
   Although the success 
of this reaction in the synthesis of RK-397 provided strong precedence for its 
application in the dermostatin A synthesis, the compound’s polyol portions differed, 
eliminating any guarantee of success.  Gratifyingly, the same trienal piece 21 
underwent selective metathesis with the terminal olefin in the polyol portion of 
dermostatin A, 23 (Scheme 1.11).  Again, 24 was the only metathesis product isolated 
from the reaction mixture, showing the selectivity of the distal olefin towards CM 
over the two olefins proximal to the aldehyde.  Moderate E/Z selectivity of the newly-
formed olefin was again seen in a 4:1 ratio. 
Scheme 1.11.  Key CM Reaction in the Total Synthesis of Dermostatin A. 
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1.4 Previous Polyene Cross-Metathesis Studies 
 
While elucidating an empirical model for product-selective cross-metathesis, 
Grubbs and co-workers also found that the same model could be applied to 
chemoselective CM reactions with polyolefinic substrates.
15
  In principle, CM would 
take place with a Type I or Type II olefin in the presence of a Type IV olefin with a 
given catalyst.  And as a proof of concept they showed that the metathesis reaction 
between substrates 25 and 26 (Scheme 1.12) provided the desired cross-product 
between the Type I olefin in the diene substrate (with catalyst 2) and the olefin of 
substrate 26.  No metathesis took place between the electronically deactivated Type 
IV olefin of the diene and substrate 26, exemplifying the chemoselectivity of the CM 
reaction.  Blechert et al. used steric constraints to implement selectivity for a Type I 
olefin in the presence of a Type IV between substrates 27 and 28 with catalyst 2 as 
shown in Scheme 1.12.
26
  And with catalyst 1, Crowe and Zhang showed the 
chemoselective reaction between the Type I olefin in 29 and the Type II olefin in 30 
in the presence of a Type IV olefin (Scheme 1.12).
27
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Scheme 1.12.  Chemoselective CM Based on Olefin Categorization. 
 
 In addition to chemoselective CM reactions, Grubbs’ olefin classifications 
also enable the development of multicomponent processes.
15
  In their study, Grubbs et 
al. demonstrate the execution of a three-component CM reaction.  This was done by 
first taking advantage of the fact that secondary metathesis reactions can be much 
slower than productive CM reactions.  Then by using two olefins which do not react 
readily with one another, a third diene-containing substrate could be functionalized at 
both olefins unsymmetrically.  A successful example of this concept is the first 
reaction shown in Scheme 1.13 where olefins of Types I, II and III are all combined 
to make one product selectively.  In this reaction, one of the Type I dienyl-olefins and 
the Type II olefin readily react and the resulting diene is only reactive at the site distal 
to the carbonyl, which then reacts with the Type III olefin that remains in solution.  
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Scheme 1.13.  Three-Component CM Reactions. 
 
 The reaction described at the bottom of Scheme 1.13 shows that two Type I 
olefins can be utilized in a three-component CM reaction by simply applying a 
sequential addition strategy.
15
  Similarly as before, one of the diene olefins first reacts 
with the Type II olefin in solution and the resulting diene reacts with styrene upon 
addition only at the olefin distal to the carbonyl.  Had the diene and styrene not been 
sequentially added, a non-selective mixture of products would have resulted. 
Not only do many natural products contain multiple olefins, but conjugated 
polyene moieties are also abundant.  However, few synthetic studies have been 
undertaken in efforts to build these conjugated scaffolds via olefin metathesis because 
of potential issues regarding chemo- and diastereoselectivity in the metathesis 
reactions.  Grubbs and co-workers cleverly circumvent these issues, however, in their 
study involving dienes via deactivation or ―protection‖ of a specific olefin.28  This is 
accomplished by attaching an electron-withdrawing or sterically bulky substituent to 
one of the olefins in the conjugated diene, leaving the remaining olefin more reactive 
and available to participate in the metathesis reaction.  Their initial study consisted of 
ethyl sorbate (31) as the conjugated diene and 5-hexenyl acetate (32) as the 
metathesis partner.  With catalyst 2, however, only homocoupling of 32 occurred 
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indicating that both of the olefins in 31 were too deactivated (Scheme 1.14).  Upon 
switching to catalyst 3, a mixture of metathesis proximal and distal to the electron-
withdrawing ester took place, in this case indicating that both olefins were rendered 
too reactive. 
Scheme 1.14.  Grubbs' Initial Attempts at Achieving Selectivity with Conjugated 
Dienes. 
 
 To increase the deactivation and steric bulk of the α,β-olefin, a vinyl bromide 
was added to the α-carbon (compound 35 in Table 1.1).  When this substrate was 
paired with reactive monoenes and subjected to the reaction conditions with catalyst 3 
(Grubbs II), the desired cross-products were formed with metathesis occurring solely 
at the γ,δ-olefin.  The electron-withdrawing group is now sufficient enough to 
deactivate the proximal olefin while leaving the distal olefin reactive enough to 
participate in the metathesis reaction.  Representative examples of their study are 
given in Table 1.1.  As shown in entries 4 and 5, the dibromo moiety was also able to 
sufficiently deactivate the proximal olefin to give the desired cross-products. 
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Table 1.1. Olefin CM with Electron-Poor Dienes.
a
 
 
 Grubbs et al. were also able to support their hypothesis of the ability to 
―protect‖ a particular olefin via steric bulk in the CM reaction.28  This was carried out 
by introducing substitution around one of the olefins of the conjugated diene.  As 
shown in Table 1.2, 1,2-disubstituted butadienes and even 2-substituted butadienes 
were viable metathesis partners with the reaction only taking place at the 3,4-olefin 
with catalyst 3 (Grubbs II).  
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Table 1.2. Olefin CM Using 1,2-Disubstituted and 2-Substituted 1,3-Butadienes.
a 
 
Both electron-rich and electron-poor mono-olefins reacted to give good yields 
and high chemo- and diastereoselectivity.  Many of the compounds in Grubbs’ study 
are useful synthetic intermediates and can be easily functionalized further, displaying 
the utility and viability of achieving selectivity in CM reactions with conjugated 
dienes via electronic or steric deactivation of a single olefin. 
 The previously described study by Grubbs et al. served as a departure point 
for Curran and Moura-Letts in their analysis of synthesizing (2Z,4E)-dienyl esters via 
CM for their synthesis of dictyostatin (discussed earlier).  They were intrigued by 
Grubbs’ finding that olefins of a conjugated system can be electronically deactivated 
towards CM, and they hoped the trend would extend to less stable (Z)-1,2-
disubstituted alkenes.
22
  Furthermore, they hoped that selective CM would take place 
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without Z-alkene isomerization.  After solvent, temperature and stoichiometric 
variables were surveyed, Curran and Moura-Letts were pleased to find conditions that 
gave high yields of the dienyl fragment of dictyostatin along with many other 
(2Z,4E)-dienyl esters.  Representative examples of their study are given in Table 1.3. 
Table 1.3. CM Reactions with (2Z,4E)-Dienyl Esters.
a
 
 
 Gratifyingly, all products were exclusively Z-isomers at the olefin proximal to 
the ester, indicating that the olefin was sufficiently deactivated and served as a 
spectator to CM reactions with catalyst 3 (Grubbs II).  Changing the secondary 
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alcohol protecting group and the use of a free primary alcohol all gave the CM 
products in comparable yields (Table 1.3, entries 1-3), and metathesis with the 
complex triene in entry 4 provided a single tetraene isomer in 76% yield.  Further 
proof that the α,β-alkene serves as a spectator olefin in the reaction can be seen in 
entries 5-8 where the geometry of this olefin in the product does not change.  All of 
the products were single stereoisomers at both the reacting (4E) and spectator (2Z) 
sites. 
 
1.5 Cross-Metathesis of Electron-Deficient Polyenes 
 
En route to our group’s total syntheses of RK-397 and dermostatin A, the 
viability of a CM reaction between an electron-deficient polyene and a terminal olefin 
became a pressing question.  Initial effort in answering this question was made by a 
previous graduate student in the Sammakia group, Dr. Aaron Cullen.  Using the 
completed polyol portion of RK-397 (20) as the metathesis partner, he performed a 
survey of CM reactions with polyenals containing one to four olefins (Scheme 1.15). 
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Scheme 1.15.  Initial Efforts in Completing the Polyene Portion of RK-397. 
  
The preliminary reaction of crotonaldehyde with 20 using catalyst 3 gave a 
promising result: 90% yield of the desired product after only one hour of reaction 
time.  However, when Dr. Cullen attempted the cross-metathesis with the dienal, he 
isolated a mixture of distal and proximal metathesis products.  As described in 
Section 1.3, CM between 20 and the trienal proved to be the most efficient route for 
the total synthesis of RK-397, as it gave the desired product in 72% yield with an E/Z 
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ratio of 4:1 at the newly formed olefin.  Dr. Cullen’s efforts to complete the polyene 
portion of the macrolide in an even more efficient fashion extended to CM attempts 
of 20 with tetraenal 36, however, this reaction merely returned starting material and 
did not provide any of the desired product. 
Having determined that the CM reaction involving a trienal was viable in our 
synthesis of RK-397, the question was then posed as to whether or not CM with 
electron-deficient polyenes was general.  It was also noted that no systematic study of 
the cross-metathesis of a terminal alkene with polyenes conjugated to an electron-
withdrawing group had been reported to our knowledge.  Thus, we undertook such a 
study. 
1.5.1 Polyene Study 
For our study, we chose as one of the components terminal alkene 37
29
 which 
falls into the highest reactivity type for all the common Ru metathesis catalysts (Type 
I, according to Grubbs’ nomenclature), and is a representative terminal alkene.  We 
studied the cross-metathesis of 37 with alkenes, dienes, trienes, and tetraenes 
conjugated to an aldehyde or ester as shown in Scheme 1.16.
15,28,30-38
 These 
compounds are of different reactivity types (we speculated types I - III depending on 
the choice of catalyst) and as such, we suspected they would require different 
catalysts and conditions to promote selective cross-metathesis with 37.  The problems 
we anticipated included the reticence of electron-deficient olefins to participate in 
metathesis reactions, and in the case of dienes-tetraenes, issues of selectivity with 
respect to metathesis of the terminal versus internal olefins.
39
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Our results with each aldehyde-derived substrate and catalysts 2 - 4 are shown 
in Table 1.4.  Reactions were run with a 10% catalyst loading in dichloromethane at 
reflux with 37 as the limiting reagent given that in an application of this method, the 
terminal alkene would likely be the more valuable component.  In addition, 
preventing homodimerization of 37 was also necessary, resulting in an excess of the 
electron-deficient alkene.  This excess was minimized as much as possible; however, 
most reactions still necessitated a stoichiometry of 1:2 37/polyene substrate.  We then 
studied each substrate pair with each catalyst and noted the following trends.  In 
many cases, we found that the reactions stalled after some time, presumably due to 
catalyst inactivation or decomposition, and we observed incomplete consumption of 
37.  In some reactions, conversion of 37 to the corresponding dimer (38) was 
prominent; thus, while consumption of 37 was high, conversion to the desired product 
was low.  At times, complex mixtures of products were observed, again with 
consumption of 37.   
Scheme 1.16.  Cross-Metathesis with Electron-Deficient Polyenes. 
 
For the cross-metathesis of acrolein and crotonaldehyde we found that these 
electron-deficient substrates failed with the less active first-generation Grubbs 
catalyst (2)
40-42
: in the case of acrolein, the reaction stalled at low conversion, and in 
the case of crotonaldehyde, most of 37 was converted to dimer 38 (36% which 
consumes 72% of 37) and provided the desired product in only 16% conversion.  This 
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result reaffirms that α,β-unsaturated carbonyls are spectator olefins (Type IV) to 
metathesis with catalyst 2 as postulated by Grubbs in his model for CM selectivity.
15
  
The more active second-generation Grubbs catalyst (3),
10,11
 or the phosphine-free 
variant (4) described by Hoveyda
12
 and by Blechert
13
 provided superior results.  In 
regards to crotonaldehyde, catalysts 3 and 4 were essentially equivalent; both 
provided complete consumption of 37 and cleanly provided the desired product in 
91% and 94% yield respectively.  Acrolein requires the more active catalyst 4 to 
proceed to complete conversion, presumably because it is less reactive than 
crotonaldehyde, and provided the product in a yield of 75%.  All of this data is 
consistent with Grubbs’ model for selectivity in CM reactions since the electron-
deficient olefin is most certainly of Type II or III for catalysts 3 and 4, and therefore 
productive CM with the Type I olefin in 37 was anticipated. 
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Table 1.4. Cross-Metathesis of 37 with Enal and Polyenal Substrates (Scheme 1.16). 
 
We were unable to obtain satisfactory results with dienal 41
23
 due to either 
reactivity or selectivity problems.  In the case of the least reactive first-generation 
Grubbs catalyst (2), the reaction cleanly proceeded to the desired product, but 
consistently stalled at about 12% conversion.  The more reactive catalysts (3 and 4) 
provided higher conversion, but suffered from poor selectivity for the terminal alkene 
(1.7:1 ratio of terminal to internal metathesis with catalyst 3, and 1.2:1 ratio of 
terminal to internal metathesis with catalyst 4).  We conclude that dienal 41 is too 
unreactive for catalyst 2 (as seen with acrolein and crotonaldehyde), yet with catalysts 
3 and 4 the substrate is too reactive and metathesis takes place at both olefins.  These 
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results are in accord with Grubbs’ findings on the reactivity of conjugated dienes with 
ethyl sorbate previously discussed.
28
 
In contrast, we were pleased to find that trienal 42
23
 is a competent substrate, 
but only with the least active of the catalysts.  In this substrate, the electron-
withdrawing aldehyde is sufficiently removed from the terminal alkene that it is 
reactive enough for the first-generation Grubbs catalyst while the internal alkenes are 
not.  The product is formed as a 4:1 mixture of E- to Z- olefin isomers at the distal 
(ε,δ) alkene.  A variety of conditions were studied, however, we were unable to 
improve this ratio.  Surprisingly, reactions with the more reactive catalysts stalled 
after about 33% consumption of 37 and were not clean, suggesting catalyst 
decomposition during the reaction.  Similarly, reactions with tetraenal substrate 43 
also provided complex mixtures by NMR with all catalysts and under all conditions 
studied, and stalled after low consumption of 37 (30 - 41%). 
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Table 1.5. Cross-Metathesis of 37 with Enoate and Polyenoate Substrates (Scheme 
1.16). 
  
Similar results were obtained with the ester-derived substrates (Table 1.5).  In 
the case of ethyl acrylate or ethyl crotonate, again, the less active first-generation 
Grubbs catalyst (2) provided significant amounts of dimer 38 (32% which consumes 
64% of 37, and 36% which consumes 72% of 37, respectively).  The more reactive 
catalysts (3 and 4) provided the desired product in 70% to 92% yield (Table 1.5, 
entries 2, 3, 5 and 6). 
Dienoate 46
43
 did not provide satisfactory results with any of the catalysts 
studied.  While the consumption of 37 was high in many reactions, several 
unidentified side products were observed and we were unable to discover conditions 
32 
 
which provided clean reactions.  When the most reactive catalyst was used, 4, the 
reaction suffered from a lack of selectivity and a 2:5 ratio of terminal to internal 
metathesis was observed.  This result is reminiscent of that obtained with dienal 
substrate 41; however, the preference for formation of the internal metathesis product 
is interesting to note.  Assuming metathesis first takes place at the terminal olefin, it 
is surprising that this initial product is still reactive enough with catalyst 4 to 
participate in subsequent metathesis events given its bulkiness and electronics. 
As in the case of trienal 42, cross-metathesis with trienoate 47
23
 provided 
good conversion and high yields with the first-generation Grubbs catalyst (96% 
consumption of 37, 84% yield) and a 5:1 ratio of E- to Z- olefin isomers at the distal 
(ε,δ) alkene.  The more active catalysts stalled at lower conversion, again presumably 
due to catalyst inactivation or decomposition.
44
  Similar to the trienal, the terminal 
olefin in 47 differs significantly in reactivity when compared to the internal olefins, 
therefore promoting selective CM.  It should be noted that due to the co-elution of 
excess starting material and product during purification by flash column 
chromatography, the isolated yield of the cross-product is over two steps: CM and 
then deprotection of the silyl ether in the product with HF-acetonitrile.  The 
tetraenoate substrate provided slightly better results than the tetraenal.  With the first-
generation Grubbs catalyst we observed a 62% conversion to the desired product by 
NMR; however, we were unable to isolate the product cleanly by flash column 
chromatography.  The more active catalysts stalled at low conversion likely due to 
catalyst decomposition. 
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1.5.2 Synthesis of Polyene Substrates 
The synthesis of 46 is described in Scheme 1.17 and begins with the formation 
of a half-acid ester of ethyl malonate which undergoes a Knoevenagel condensation 
with acrolein to give 46 in a yield of 36%. 
Scheme 1.17.  Preparation of Substrate 46 (Table 1.4, Entries 4, 5, 6). 
 
 Synthesis of the dienal proved to be a little more difficult.  Since the 
formation of 46 was somewhat low-yielding, a different route to the dienal was 
explored.  Instead of using the three-step process to the dienoate, the one-step 
formation of the dieneacid (50) via a Knoevenagel condensation between 49 and 
acrolein was utilized.  This was followed by a reduction to the dienol (51) and 
subsequent oxidation to the dienal, and it seemed to be a very straightforward route.  
However, problems were observed in the reduction step and after much 
experimentation with several different methods, in-situ formation of the mixed 
anyhydride followed by reduction via sodium borohydride proved to be the most 
reproducible method (albeit low-yielding).
45
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Scheme 1.18.  Preparation of Substrate 41 (Table 1.4, Entries 4, 5, 6). 
 
 Synthesis of the triene pieces was straightforward and produced modest yields 
of 42 and 47.  A simple Horner-Wadsworth-Emmons reaction
46
 with 41 gave the 
trienoate, 47, which was then taken on to trienal 42 via DIBAL-H reduction to the 
trienol (52) followed by oxidation with Dess-Martin periodinane (Scheme 1.19). 
Scheme 1.19.  Preparation of Substrates 42 and 47 (Tables 1.4 and 1.5, Entries 7, 8, 
9). 
 
 Finally, as shown in Scheme 1.20, tetraenes were synthesized in a 
straightforward fashion by the same method used for the synthesis of the triene 
substrates.  Horner-Wadsworth-Emmons reaction of 42 with 53 provided 48, which 
was subjected to reduction and oxidation to give 43. 
35 
 
Scheme 1.20.  Preparation of Substrates 43 and 48 (Tables 1.4 and 1.5, Entries 10, 
11, 12). 
 
 
1.6 Conclusion and Future Direction 
 
In conclusion, we have shown that the cross-metathesis of acrolein, ethyl 
acrylate, crotonaldehyde and ethyl crotonate with terminal alkene 37 proceeds in high 
yields using the more active ruthenium catalysts (3 or 4), while trienal 42 and 
trienoate 47 require the least active catalyst 2.  We attribute this to the reactivity of 
the terminal olefin of the triene which is furthest removed from the electron-
withdrawing aldehyde or ester, rendering it the only alkene capable of reacting with 
this catalyst.  Diene and tetraene substrates were not good partners in this reaction 
due to a lack of differentiation of the alkenes.  Although one could speculate that 
polyenes larger than a tetraene would suffer from the same lack of olefin 
differentiation in cross-metathesis reactions, it would still be interesting to test such a 
hypothesis in future work.  With the development of more reactive or more selective 
catalysts,
47-49
 CM reactions with tetraenes and higher with these new catalysts could 
be viable. 
Other future work in this study includes the completion of the total synthesis 
of RK-397 via an intramolecular ring closing metathesis reaction instead of a 
36 
 
macrolactonization.  Having determined that monoenes and trienes are viable cross-
metathesis partners, one could imagine this ring closing metathesis reaction in three 
different scenarios (Scheme 1.21).  First, the cyclization could take place between a 
trieneoate fragment and a monoene bearing a protected homoallylic alcohol, as in 
substrate 54.  The product would then be subjected to selective elimination to give the 
desired target.  A preliminary study would need to be conducted prior, which would 
examine the coupling in an intermolecular sense between substrates 47 and 57 
(Scheme 1.22). 
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Scheme 1.21.  Ring Closing Metathesis Alternatives in Completing the Total 
Synthesis of RK-397. 
 
 A second option would involve the ring closing metathesis of two conjugated 
triene moieties as in substrate 55 from Scheme 1.21.  Again, an intermolecular model 
study using similar substrates (47 and 58, Scheme 1.22) would confirm the viability 
of this reaction in a simpler context.  This approach would be especially interesting 
since it would form the macrolide in the most efficient fashion, and it would provide 
information about the selectivity of a CM reaction involving two polyenes. 
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Scheme 1.22.  Preliminary Intermolecular Studies to Assess Viability of Similar 
Metathesis Reactions in an Intramolecular Setting. 
 
The third and final possibility presented in Scheme 1.21 consists of the 
intramolecular RCM of two monoene pieces, such as in 56.  The product of which 
would then be subjected to selective elimination and deprotected to give RK-397.  Of 
course, the study would need to begin with an intermolecular cross-metathesis 
between similar monoene pieces 44 and 59 to assess whether or not the reaction 
would be viable (Scheme 1.22).  In any and all of the aforementioned studies, it will 
be interesting to compare the selectivity for the terminal olefin versus internal olefins 
in the inter- and intramolecular reactions. 
 
1.7 Experimental Information 
 
General Information:  
All reactions were conducted in oven-dried glassware under a dry nitrogen 
atmosphere.  Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled over 
sodium benzophenone ketyl under nitrogen.  Dichloromethane (CH2Cl2), pyridine, 
and triethylamine (NEt3) were distilled over CaH2 under nitrogen.  Acrolein, 
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crotonaldehyde, ethyl acrylate, and ethyl crotonate were distilled under nitrogen prior 
to use.  Diethyl malonate, 4-dimethylaminopyridine (DMAP), malonic acid, 
methylchloroformate, sodium borohydride, chloroform, diisobutylaluminum hydride 
(DIBAL-H, 1.0M in hexanes), sodium hydride (60% in mineral oil), triethyl 
phosphonoacetate, benzylidenebis(tricyclohexylphosphine)-dichlororuthenium (2), 
(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro-phenylmethylene) 
(tricyclohexyl-phosphine) ruthenium (3), and (1,3-Bis-(2,4,6-trimethylphenyl)-2-
imidazolidinylidene) dichloro(o-isopropoxyphenyl-ethylene)ruthenium (4) were 
purchased from the Aldrich Chemical Company and used as received.  Flash column 
chromatography was performed using 60 Å silica gel (32-63 μm).  1H NMR spectra 
were obtained at 500 MHz or 400 MHz and 
13
C NMR spectra at 125 or 100 MHz in 
CDCl3 as indicated.  Chemical shifts are reported in ppm referenced to CHCl3 (7.24 
ppm for 
1
H) and CDCl3 (77.0 ppm for 
13
C).  IR spectra were recorded as thin films on 
NaCl plates.  Exact mass was obtained using electrospray ionization in positive ion 
mode (M+H, or M+Na, or M+Li) or in negative ion mode (M+Cl) as indicated. 
3-Ethoxy-3-oxopropanoic acid
50
: 
 
 Diethyl malonate (50 g, 312 mmol, 1.0 equiv) was dissolved in absolute 
ethanol (200 mL) and a solution of potassium hydroxide (17.5 g, 312 mmol, 1.0 
equiv) in absolute ethanol (200 mL) was added dropwise over 1 h.  The reaction 
mixture was allowed to stir at room temperature for 2 h, then heated to reflux and 
allowed to stir for 1 h (during which all solids dissolved), and then left to stand at 
room temperature overnight.  The crude precipitate was recrystallized from the 
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mother liquors and washed with Et2O to give the known potassium salt as a colorless 
crystalline solid (45.4 g, 267 mmol, 85%). 
 To a cooled (0 °C) solution of the above salt (45.4 g, 267 mmol, 1.0 equiv) in 
DI H2O (27 mL) was added concentrated HCl (23.4 mL, 280 mmol, 1.05 equiv) 
slowly over 30 min.  The reaction mixture was allowed to stir at room temperature for 
20 min, and was then filtered through cotton, rinsing with Et2O.  The filtrate was then 
transferred to a separatory funnel and the aqueous layer was extracted with Et2O (2 × 
50 mL).  The combined organic layers were dried over MgSO4, filtered through 
Celite, and concentrated under reduced pressure to give the known half-acid (27.2 g, 
206 mmol, 77%) as a colorless oil. 
 IR (cm
-1
): 3486, 1743, 1735.  NMR (500 MHz, CDCl3): δ 1.29 (3H, t, J = 7 
Hz), 3.43 (2H, s), 4.23 (2H, q, J = 7Hz), 8.21 (1H, br s). 
(E)-ethyl penta-2,4-dienoate (46)
43
: 
 
To a cooled (0°) solution of the half-acid (27.2 g, 206 mmol, 1.5 equiv) in 
pyridine (45.7 mL) was added acrolein (9.15 mL, 137 mmol, 1.0 equiv) dropwise via 
syringe.  4-Dimethylaminopyridine was then quickly added to the reaction flask upon 
brief exposure to air.  The reaction flask was heated to 90 °C and allowed to stir 
overnight.  The deep orange solution was then allowed to cool to room temperature 
and poured into a separatory funnel already containing DI H2O (300 mL).  Et2O  
(40 mL) was added to the separatory funnel, the layers were separated, and then the 
aqueous layer was extracted with Et2O (3×40 mL).  The combined organic layers 
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were then washed with 1 M HCl (3×20 mL), dried over MgSO4, filtered through 
Celite, and concentrated under reduced pressure to give an orange solution.  The 
crude reaction mixture was then purified by distillation under low vacuum (65-67 °C) 
to give the known dienoate 46 as a colorless oil (6.17 g, 48.9 mmol, 36%).  
IR: 1700, 1640, 1560, 1440, 1365, 1175, 1030, 980, 915 cm
-1
.  
1
H NMR (500 
MHz, CDCl3): δ 7.24 (dd, J = 15.5, 11.0, 1H), 6.50 – 6.37 (m, 1H), 5.95 – 5.84 (m, 
1H), 5.62 – 5.43 (m, 2H), 4.18 (q, J = 7.1, 2H), 1.28 (t, J = 7.1, 3H).  13C NMR (25 
MHz, CDCl3): δ 166.8, 144.6, 134.8, 125.4, 122.3, 60.3, 14.3. 
(E)-penta-2,4-dienoic acid (50)
51
: 
 
To a heated (40 °C) solution of malonic acid (2.0 g, 19.2 mmol, 1.0 equiv) in 
pyridine (3 mL) was added acrolein (1.7 mL, 25.0 mmol, 1.3 equiv) dropwise via 
syringe.  The reaction was allowed to stir until the evolution of CO2 had ceased and 
then was allowed to cool to room temperature.  The reaction mixture was then poured 
into a flask containing ice (12 g) and was acidified by the dropwise addition of 
concentrated H2SO4 (1.4 mL, 26.9 mmol, 1.4 equiv).  The reaction mixture was then 
transferred to a separatory funnel and the aqueous layer was extracted with CH2Cl2 
(3×10 mL).  The combined organic layers were then dried over MgSO4, filtered 
through Celite and concentrated under reduced pressure.  The crude yellow-white 
solid was then recrystallized from hexanes to give the known acid 50 (1.09 g, 11.1 
mmol, 58%) as a white crystalline solid. 
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IR: 3000, 1685, 1640, 1600, 1400, 1220 cm
-1
.  
1
H NMR (500 MHz, CDCl3): δ 
11.83 (br s, 1H), 7.34 (dd, J = 15.4, 11.1, 1H), 6.54 – 6.39 (m, 1H), 5.96 – 5.84 (m, 
1H), 5.69 – 5.50 (m, 2H). 
(E)-penta-2,4-dien-1-ol (51)
52
: 
 
 To a cooled (0 °C) solution of 50 (20 g, 204 mmol, 1.0 equiv) in THF (1 L) 
was added triethylamine (31.2 mL, 221 mmol, 1.1 equiv) and methylchloroformate 
(17.3 mL, 221 mmol, 1.1 equiv) both dropwise via syringe.  The reaction mixture was 
allowed to warm to room temperature and stir for 15 mins, and was then cooled to  
-78 °C.  Sodium borohydride (38.6 g, 1020 mmol, 5.0 equiv) was then added to the 
reaction upon brief exposure to air.  The reaction mixture was allowed to warm to 
room temperature and stir for 7.5 h.  The reaction was then quenched by the addition 
of DI H2O (100 mL).  The volatiles were removed under reduced pressure, and then 
the crude reaction mixture was acidified by the addition of 1 M HCl.  The crude 
reaction mixture was then transferred to a separatory funnel and the aqueous layer 
was extracted with CH2Cl2 (3×300 mL).  The combined organics were then dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  Purification 
by flash column chromatography on silica gel (4:1 pentane/Et2O) provided the known 
dienol 51 (5.67 g, 67.0 mmol, 33%). 
1
H NMR (500 MHz, CDCl3): δ 6.43 – 6.16 (m, 2H), 5.84 (dt, J = 15.5, 5.8, 
1H), 5.30 – 5.00 (m, 2H), 4.18 (d, J = 5.9, 2H), 1.44 (br s, 1H). 
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(E)-penta-2,4-dienal (41)
23
: 
 
 To a cooled (0 °C) solution of 51 (5.12 g, 60.9 mmol, 1.0 equiv) in CH2Cl2 
(300 mL) was added Dess-Martin Periodinane
53
 (32.3 g, 76.1 mmol, 1.25 equiv) upon 
brief exposure to air.  The reaction was allowed to warm to room temperature and stir 
overnight.  Then the reaction mixture was filtered through Celite, rinsing with 
CH2Cl2, and then quenched by the addition of 1:1 NaHCO3:Na2S2O3 (300 mL) and 
allowed to stir for 2 h.  The crude mixture was then transferred to a separatory funnel 
and the organic layer was washed with NaHCO3 (3×100 mL) and the combined 
aqueous layers were extracted with CH2Cl2 (1×100 mL).  The combined organics 
were then dried over MgSO4, filtered through Celite and concentrated under reduced 
pressure.  Purification by flash column chromatography on silica gel (CH2Cl2) 
provided the known dienal 41 (4.27 g, 52.0 mmol, 85%).  
 
1
H NMR (500 MHz, CDCl3): δ 9.58 (d, J = 7.9 Hz, 1H), 7.08 (dd, J = 15.4, 
10.9 Hz, 1H), 6.58 (dddd, J = 16.9, 11.4, 10, 0.7 Hz, 1H), 6.16 (ddd, J = 15.4, 7.9, 0.5 
Hz, 1H), 5.71-5.75 (m, 1H), 5.60-5.63 (m, 1H).  
13
C NMR (100 MHz): δ 193.8, 
151.9, 134.8, 132.4, 127.6. 
(2E,4E)-Ethyl hepta-2,4,6-trienoate (47)
23
: 
 
 To a cooled (0 °C) suspension of sodium hydride (1.5 g, 60% in mineral oil, 
37.5 mmol, 1.4 equiv) in THF (134 mL) was added triethyl phosphonoacetate (8.1 
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mL, 40.0 mmol, 1.5 equiv) slowly via syringe. Rapid hydrogen gas evolution 
occurred as the sodium hydride was consumed.  After stirring at 0 °C for 30 min, a 
solution of 41 (2.20 g, 26.8 mmol, 1.0 equiv) in THF (10 mL) was added via cannula 
and the resulting red solution was set to reflux. The reaction was allowed to stir for  
16 h, and was then quenched with saturated NaHCO3 (10 mL). The crude reaction 
mixture was transferred to a separatory funnel and the aqueous layer was extracted 
with Et2O (3×10 mL).  The combined organic layers were extracted with brine, dried 
over MgSO4, filtered through Celite, and concentrated under reduced pressure.  
Purification by flash column chromatography on silica gel (20:1 hexanes/ethyl 
acetate) provided the known trienoate 47 as a colorless oil (2.12 g, 14.0 mmol, 52%). 
IR (cm
-1
): 2924, 2360, 2342, 1718, 1266, 1182, 1031.  
1
H NMR (500MHz, 
CDCl3): δ 7.28 (dd, J = 15.3, 11.2 Hz, 1H), 6.53 (dd, J = 15, 10.8 Hz, 1H), 6.40 (ddd, 
J = 16.7, 10.4, 10.4 Hz, 1H), 6.30 (dd, J = 15, 11.2 Hz, 1H), 5.88 (d, J = 15.3 Hz, 
1H), 5.40 (d, J = 16.7 Hz, 1H), 5.29 (d, J = 10 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 1.28 
(t, J = 7.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ 167.0, 144.1, 140.8, 136.2, 130.4, 
121.6, 121.6, 60.3, 14.3.  HRMS m/z calcd for C9H12O2 + H
+
, 153.0910; found: 
153.0906. 
(2E,4E)-Hepta-2,4,6-trienal (42)
23
: 
 
To a cooled (-78 °C) solution of 47 (2.10 g, 14.0 mmol, 1.0 equiv) in CH2Cl2 
(35 mL) was added DIBAL-H (29.0 mL, 1M in hexanes, 90.0 mmol, 2.1 equiv) 
slowly via cannula.  The ice bath was removed and the reaction was allowed to stir 
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for 4 h at room temperature.  The reaction was then diluted with Et2O (35 mL), and 
quenched by the sequential addition of DI H2O (1.5 mL), 1M NaOH (3 mL), and 
additional DI H2O (1.5 mL) resulting in the formation of a white precipitate.  This 
suspension was allowed to stir for 30 min then MgSO4 was directly added and the 
mixture was stirred for an additional 5 min. The solution was filtered through Celite 
and concentrated under reduced pressure to cleanly provide the desired trienol (1.40 
g, 13.0 mmol, 92%) as a white solid. A portion of this material was used directly in 
the next reaction without further purification. 
To a cooled (0 °C) solution of the above trienol (400 mg, 3.60 mmol, 1.0 
equiv) in CH2Cl2 (18 mL) was added Dess-Martin Periodinane
53
 (1.60 g, 3.80 mmol, 
1.05 equiv) upon brief exposure to air.  The reaction was allowed to warm to room 
temperature and stir overnight.  Then the reaction mixture was filtered through Celite, 
rinsing with CH2Cl2, and then quenched by the addition of 1:1 NaHCO3:Na2S2O3 (20 
mL) and allowed to stir for 2 h.  The crude mixture was then transferred to a 
separatory funnel and the organic layer was washed with saturated NaHCO3 (3×10 
mL) and the combined aqueous layers were extracted with CH2Cl2 (1×10 mL).  The 
combined organics were then dried over MgSO4, filtered through Celite and 
concentrated under reduced pressure.  Purification by flash column chromatography 
on silica gel (CH2Cl2) provided a 10:1 isomeric mixture of the known trienal 42 (366 
mg, 3.40 mmol, 93%) as a translucent yellow oil.  
IR (cm
-1
): 3021, 2817, 2730, 1681, 1615, 1168, 1114, 1017, 979, 918, 887.  
1
H NMR (500 MHz, CDCl3): δ 9.56 (d, J = 8.0 Hz, 1H), 7.11 (dd, J = 15.3, 11.1 Hz, 
1H), 6.65 (dd, J = 15.0, 10.1 Hz, 1H), 6.40-6.50 (m, 2H), 6.16 (dd, J=15.2, 7.9 Hz, 
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1H), 5.48 (d, J = 17.3 Hz, 1H), 5.40 (d, J = 10.5 Hz, 1H). 
13
C NMR (100 MHz, 
CDCl3): δ 193.5, 151.5, 142.7, 135.9, 131.8, 130.4, 123.3. 
(2E,4E,6E)-Ethyl nona-2,4,6,8-tetraenoate (48): 
 
To a cooled (0 
o
C) suspension of sodium hydride (776 mg, 60% in mineral oil, 
19.4 mmol, 1.2 equiv) in THF (75 mL) was added triethyl phosphonoacetate (3.85 
mL, 19.4 mmol, 1.2 equiv) slowly via syringe.  Rapid hydrogen gas evolution 
occurred as the sodium hydride was consumed.  After stirring at 0
 o
C for 30 min, a 
solution of 42 (1.75 g, 16.2 mmol, 1.0 equiv) in THF (6 mL) was added via cannula 
and the resulting red solution was heated to reflux.  After 16 h, the reaction was 
quenched by the addition of saturated NaHCO3 (10 mL) and the mixture was 
transferred to a separatory funnel.  The aqueous layer was extracted with Et2O (3×10 
mL).  The combined organic layers were washed with brine (1×10 mL), dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  Purification 
by flash column chromatography on silica gel (20:1 hexanes/EtOAc) provided the 
tetraenoate 48 as a white, flaky solid (1.84 g, 10.3 mmol, 64%). 
IR  (cm
-1
): 3016, 2991, 1703, 1263, 1156, 1013.  
1
H NMR (500 MHz, CDCl3): 
δ 7.30 (dd, J = 26.5, 11.5 Hz, 1H), 6.55 (dd, J = 14.5, 10.5 Hz, 1H), 6.34-6.26 (m, 
4H), 5.86 (d, J = 15.5 Hz, 1H), 5.32 (d, J = 15.0 Hz, 1H), 5.21 (d, J = 9.5 Hz, 1H), 
4.19 (q, J = 7.0 Hz, 2H), 1.28 (t, J = 7.0 Hz, 3H).  
13
C NMR (100 MHz, CDCl3): δ 
167.3, 144.5, 140.5, 137.6, 136.8, 132.5, 130.7, 121.2, 120.1, 60.6, 14.6.  HRMS m/z 
calcd for C11H14O2 + Li
+
: 185.1148; found: 185.1159. 
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(2E,4E,6E)-Nona-2,4,6,8-tetraenal (43): 
 
To a cooled (-78 
o
C) solution of 48 (500 mg, 2.81 mmol, 1.0 equiv) in CH2Cl2 
(7 mL) was slowly added DIBAL-H (5.9 mL, 1M in hexanes, 5.9 mmol, 2.1 equiv) 
via cannula.  The ice bath was removed and the reaction was allowed to stir for 4 h at 
room temperature.  The reaction was diluted with Et2O (7 mL), and quenched by the 
sequential addition of DI H2O (0.5 mL), 1M NaOH (1 mL), and additional DI H2O 
(0.5 mL) resulting in the formation of a white precipitate.  This suspension was stirred 
for 30 min then MgSO4 was added and the mixture was stirred for an additional  
5 min.  The solution was filtered through Celite and concentrated under reduced 
pressure to provide the desired tetraenol (355 mg, 2.61 mmol, 93%) as a white solid.  
A portion of this material was used directly in the next reaction without further 
purification. 
 To a cooled (0 
o
C) solution of the tetraenol (28 mg, 0.21 mmol, 1.0 equiv) in 
CH2Cl2 (2 mL) was added Dess-Martin Periodinane
53
 (96 mg, 0.23 mmol, 1.1 equiv) 
in one portion.  The suspension was slowly warmed to room temperature and allowed 
to stir overnight.  The mixture was then filtered through a plug of silica over a pad of 
Celite, rinsing with CH2Cl2 (5 mL), and then quenched by the addition of 1:1 
NaHCO3/Na2S2O3 (10 mL) and allowed to stir for 2 h.  The crude mixture was then 
transferred to a separatory funnel and the organic layer was washed with NaHCO3 
(3×3 mL) and the combined aqueous layers were extracted with CH2Cl2 (1×3 mL).  
The combined organics were then dried over MgSO4, filtered through Celite and 
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concentrated under reduced pressure.  Purification by flash column chromatography 
on silica gel (CH2Cl2) provided (CH2Cl2) provided tetraenal 43 as a yellow oil (22.5 
mg, 0.17 mmol, 82%). 
IR (cm
-1
): 1676, 1591, 1140, 1021.  
1
H NMR (500 MHz, CDCl3): δ 9.55 (d, J 
= 8.0 Hz, 1H), 7.12 (dd, J = 15.5, 11.0 Hz, 1H), 6.68 (dd, J = 14.5, 11.0 Hz, 1H), 
6.50-6.30 (m, 4H), 6.14 (dd, J = 15.0, 8.0 Hz, 1H), 5.37 (d, J = 16.5 Hz, 1H), 5.26 (d, 
J = 10.5 Hz, 1H).  
13
C NMR (100 MHz, CDCl3): δ 193.8, 151.9, 142.5, 139.2, 136.7, 
132.1, 131.5, 130.6, 121.2.  HRMS m/z calcd for C9H10O + Li
+
: 141.0886; found: 
141.0879. 
General Metathesis Procedure: 
 
Reactions were carried out in a coldfinger apparatus in which there was no 
ground glass joint in between the condenser and reaction flask.  This was done in 
order to prevent evaporation of the solvent while carrying out the reaction under 
nitrogen at reflux overnight.  To a solution of alkene 37
29
 (50 mg, 0.17 mmol, 1.0 
equiv) and metathesis partner (1-3 equiv) in CH2Cl2 (1.72 mL) was quickly added the 
ruthenium metathesis catalyst (0.1 equiv) upon brief exposure to atmosphere.  The 
reaction was heated and allowed to stir at reflux overnight.  The suspension was then 
cooled to room temperature, filtered through a silica plug over a pad of Celite, 
washing with CH2Cl2, and concentrated under reduced pressure.  Purification via 
flash column chromatography on silica gel (40:1 hexanes/EtOAc) provided the 
product. 
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(E)-5-(tert-Butyldimethylsilyloxy)-7-phenylhept-2-enal (Table 1.4, Entries 3-6): 
 
Product was a colorless oil (51.2 mg, 0.16 mmol, 94%).  IR (cm
-1
): 3027, 
2929, 2857, 1697, 1471, 1255, 1090, 776.  
1
H NMR (500 MHz, CDCl3): δ 9.47 (d, J 
= 8.0 Hz, 1H), 7.25-7.21 (m, 2H), 7.16-7.11 (m, 3H), 6.84 (dt, J = 15.0, 7.5 Hz, 1H), 
6.10 (dd, J = 15.0, 7.5 Hz, 1H), 3.87 (quintet, J = 6.0 Hz, 1H), 2.68-2.62 (m, 1H), 
2.60-2.44 (m, 3H), 1.80-1.69 (m, 2H),  0.86 (s, 9H), 0.03 (s, 3H), 0.01 (s, 3H) .  
13
C 
NMR (100 MHz, CDCl3): δ 194.1, 155.2, 142.1, 135.2, 128.7, 128.5, 126.2, 70.8, 
40.7, 39.3, 32.0, 22.3, 18.3, -4.16, -4.24.  HRMS m/z calcd for C19H30O2Si + Na
+
: 
341.1907; found: 341.1893. 
(E)-Ethyl 5-(tert-butyldimethylsilyloxy)-7-phenylhept-2-enoate (Table 1.5, 
Entries 2, 3, 5, 6): 
 
Product was a colorless oil (43.7 mg, 0.12 mmol, 70%).  IR (cm
-1
): 3027, 
2930, 2857, 1721, 1257, 1092, 836.  
1
H NMR (500 MHz, CDCl3): δ 7.28-7.24 (m, 
2H), 7.17-7.15 (m, 3H), 6.95 (dt, J = 15.5, 7.5 Hz, 1H), 5.82 (d, J = 15.5 Hz, 1H), 
4.17 (q, J = 7.5 Hz), 3.83 (quintet, J = 6.0 Hz, 1H), 2.71-2.65 (m, 1H), 2.61-2.55 (m, 
1H), 2.43-2.34 (m, 2H), 1.77-1.73 (m, 2H), 1.27 (t, J = 7.5Hz, 3H), 0.89 (s, 9H), 0.5 
(s, 3H), 0.4 (s, 3H).  
13
C NMR (100 MHz, CDCl3): δ 166.6, 145.9, 142.4, 128.65, 
128.56, 126.1, 123.7, 71.1, 60.4, 40.4, 39.3, 32.0, 26.1, 18.3, 14.5, -4.2, -4.3.  HRMS 
m/z calcd for C21H34O3Si + H
+
: 363.2350; found: 363.2350. 
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(2E,4E,6E)-9-(tert-Butyldimethylsilyloxy)-11-phenylundeca-2,4,6-trienal (Table 
1.4, Entry 10): 
 
Product was a colorless oil (46 mg, 0.12 mmol, 70%).  IR (cm
-1
): 3026, 2929, 
2856, 1682, 1614, 1255, 1112, 836.  
1
H NMR (500 MHz, CDCl3): δ 9.54 (d, J = 8.0 
Hz, 1H), 7.28-7.24 (m, 2H), 7.18-7.15 (m, 3H), 7.10 (dd, J = 15.0, 11.0 Hz, 1H), 6.63 
(dd, J = 15.0, 10.5 Hz, 1H), 6.34 (dd, J = 15.0, 11.0 Hz, 1H), 6.24-6.10 (m, 2H), 6.02 
(dd, J = 22.5, 7.5 Hz, 1H), 3.80 (quintet, J = 6.0 Hz, 1H), 2.73-2.65 (m, 1H), 2.62-
2.54 (m, 1H), 2.41-2.31 (m, 2H), 1.76-1.72 (m, 2H), 0.90 (s, 9H), 0.50 (s, 3H), 0.3 (s, 
3H).  
13
C NMR (100 MHz, CDCl3): δ 193.9, 152.6, 143.1, 142.5, 138.6, 132.2, 131.1, 
128.6, 128.5, 126.0, 71.6, 41.2, 39.3, 32.1, 18.4, -4.1, -4.3.  HRMS m/z calcd for 
C23H34O2Si + Na
+
: 393.2220; found: 393.2202. 
(2E,4E,6E)-Ethyl 9-hydroxy-11-phenylundeca-2,4,6-trienoate (Table 1.5, Entry 
10): 
 
To a solution of alkene 37
29
 (100 mg, 0.34 mmol, 1.0 equiv) and trienoate 47 
(79 mg, 0.52 mmol, 1.5 equiv) in CH2Cl2 (3.44 mL) in a coldfinger was quickly 
added the ruthenium catalyst 2 (28 mg, 0.03 mmol, 0.1 equiv) upon brief exposure to 
atmosphere.  The reaction was heated and allowed to stir at reflux overnight.  The 
suspension was then cooled to room temperature, filtered through a silica plug over a 
pad of Celite, rinsing with CH2Cl2 (5 mL), and concentrated under reduced pressure.  
The crude mixture was then taken up in acetonitrile and transferred to a plastic, 
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conical vial and then concentrated again under reduced pressure.  To a cooled (0 °C) 
solution of this crude mixture (143 mg, 0.34 mmol, 1.0 equiv) and acetonitrile (3.45 
mL) was added hydrofluoric acid (48% in water, 0.2 mL, 14 equiv).  After stirring at 
0 
°
C for 5 min, the reaction was allowed to come to room temperature and stir 
overnight.  The reaction was then diluted with CHCl3 (5 mL) and transferred to a 
separatory funnel.  The aqueous layer was extracted with CHCl3 (3×3 mL).  The 
combined organic layers were then dried over MgSO4, filtered through Celite, and 
concentrated under reduced pressure.  Purification by flash column chromatography 
on silica gel (5:1 hexanes/EtOAc) yielded the alcohol as a yellow oil (83 mg, 0.28 
mmol, 80%). 
IR (cm
-1
): 3454, 3025, 2930, 1708, 1617, 1262, 1136.  
1
H NMR (500 MHz, 
CDCl3): δ 7.29-1.23 (m, 2H), 7.18-7.14 (m, 3H), 6.49 (dd,  J =14.5, 11.0 Hz, 1H), 
6.23-6.15 (m, 2H), 5.92-5.82 (m, 2H), 4.17 (q, J = 7.5 Hz, 2H), 3.70-3.66 (m, 1H), 
2.82-2.75 (m, 1H), 2.69-2.62 (m, 1H), 2.42-2.24 (m, 1H), 1.80-1.73 (m, 2H), 1.91 (br 
s, 1H), 1.28-1.23 (m, 3H).  
13
C NMR (100 MHz, CDCl3): δ 167.4, 144.7, 142.0, 
140.6, 135.5, 132.9, 129.0, 128.6, 126.1, 120.9, 70.5, 60.5, 41.4, 38.8, 32.2, 14.5.  
HRMS m/z calcd for C19H24O3 + Na
+
: 323.1617; found: 323.1619. 
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Chapter 2 
Studies Toward the Total Synthesis of Arenolide 
 
2.1 Arenolide Isolation, Characterization and Biological Activity 
 
While performing a high throughput cytotoxicity assay in 1998, Faulkner and 
co-workers screened a number of extracts that had not previously shown activity in 
earlier bioassays.
1
  In doing so they found promising activity in a Dysidea sp. extract 
that had been collected in 1981 in Palau and stored in methanol.  From this extract, 
they isolated three diterpenes of the dolabellane class and a 14-membered macrolide 
which the group aptly named arenolide (1, Figure 2.1) for the sponge’s “arena” or 
sandy feel to the touch. 
Figure 2.1.  Faulkner's Proposed Structure of Arenolide. 
 
Beginning with the high resolution mass measurement, Faulkner et al. were 
able to deduce arenolide’s molecular formula to be C25H42O6.  The IR spectrum 
indicated the presence of a lactone carbonyl, and 
13
C data required that there be four 
hydroxyl groups in the compound (C5, C9, C19 and C21).  The 
13
C data also 
confirmed the presence of the lactone carbonyl along with three other sites of 
unsaturation: two exocyclic methylene groups (C11 – C24 and C15 – C25), and one 
endocyclic, trisubstituted olefin (C6 – C7).  And since the molecular formula requires 
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five unsaturations, arenolide had to be monocyclic.  
1
H NMR and COSY data showed 
the sequentially coupled signals of arenolide’s side chain, and further analysis of the 
COSY, HMQC and HMBC spectra revealed the substituents around the macrolide’s 
core.  Stereochemistry around the macrocycle was determined in a relative sense 
through interpretation of the NOESY data, and was supported by molecular modeling  
However, the stereochemistry of the side chain hydroxyl groups at C19 and C21 was 
not determined and is currently unkonwn. 
Using a cell proliferation assay, arenolide showed relatively low in vitro 
cytotoxicity against HCT human colon carcinoma cells and A2780 human ovarian 
carcinoma cells after 72 hours of exposure with IC50 values of 21 mM and 9.8 mM 
respectively.  However, Faulkner proposes that much of the isolated macrolide had 
polymerized before it was assayed, indicating that its bioactivity could potentially be 
much greater.   
Faulkner and co-workers also comment on the fact that neither dolabellanes 
nor macrolides have previously been reported as being isolated from the Dysidea 
species.  After carefully re-analyzing their collection notes from the extracts and 
finding that no contamination took place across their samples, the group definitively 
concluded that the source of the isolated compounds was the collected Dysidea sp. 
sample.  As an explanation for how the sponge obtained the peculiar compounds, the 
authors hypothesize that they may have been released by organisms in the vicinity 
and then absorbed by the sponge. 
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2.2 Retrosynthetic Analysis of Arenolide 
 
The most obvious first disconnection that could be made for the retrosynthesis 
of arenolide is the C1 – oxygen bond of the macrolactone.  This bond is commonly 
formed in the forward direction via standard and reliable methods
2
 such as the 
Yamaguchi macrolactonization.
3-5
  While these methods are likely to be as reliable in 
the synthesis of arenolide as they were in their precedented uses, a more novel and 
original technique of macrocyclization is that developed by our lab using an 
intramolecular vinylogous aldol reaction.
6
  It is this method that Dr. Aaron Cullen, a 
previous graduate of the Sammakia lab, originally proposed to utilize in his 
undertaking of the total synthesis of arenolide.  In the retrosynthetic direction, this is a 
disconnection of arenolide’s C4 – C5 bond, providing the acyclic precursor, 2, Figure 
2.2. 
Figure 2.2.  Original Retrosynthesis of Arenolide. 
 
 Dr. Cullen then envisioned setting the anti stereochemical relationship 
between C9 and C13 via a 1,5-anti aldol reaction
7
 with two fragments: ketone 3 and 
aldehyde 4 (Figure 2.2).  While this method would most likely be reliable, it 
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necessitates the use of two very advanced substrates.  In efforts to streamline the 
synthesis and add flexibility, a late-stage installation of the side chain could be 
exploited, providing a simpler macrocycle, 5, as our target (Figure 2.3).  
Retrosynthesis of 5 would still utilize the key intramolecular vinylogous aldol, as well 
as a 1,5-anti aldol to build the acyclic precursor.  However, the latter reaction would 
require the less-advanced aldehyde, 7 (Figure 2.3). 
Figure 2.3.  Revised Retrosynthesis of Arenolide. 
 
 A major benefit of the revised retrosynthesis is the use of ketone 3 which is a 
common precursor in both retrosyntheses.  This substrate could be prepared via the 
asymmetric acetate aldol reaction developed in our lab, providing compound 8 and 
the known compound 9 as precursors (Figure 2.4).
8-10
  And prior work by Dr. Cullen 
showed that 8 could be synthesized by using Negishi’s zirconium-assisted 
carboalumination of alkyne 10.
11,12
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Figure 2.4.  Retrosynthesis of Ketone 3. 
 
 
2.3 Intramolecular Vinylogous Aldol 
 
In an effort to expand the scope of the reactivity of Lewis acids and to 
improve the stereo-, regio- and chemoselectivity of reactions using them, Yamamoto 
and coworkers pioneered the synthesis and use of “designer Lewis acid catalysts” in 
the late 1990s.
13,14
 Their efforts produced a new class of bulky aluminum-based 
Lewis acids where sterically hindered phenoxides replaced the classic halogen 
ligands, resulting in new and unique reactivities.  While classical aluminum Lewis 
acids in solution can exist as dimeric, trimeric, or higher oligomeric structures, 
Yamamoto’s methylaluminum bis(2,6-di-tert-butyl-4-methylphenoxide) (MAD)15, 
and aluminum tris(2,6-diphenylphenoxide) (ATPH)
16
 Lewis acids are monomeric in 
organic solvents, leading to high reactivity and selectivity. 
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One well-developed example of the new and unique reactivity of Yamamoto’s 
designer Lewis acids is that of an intermolecular vinylogous aldol reaction using his 
bulky Lewis acid, ATPH.  In this reaction, ATPH binds to an α,β-unsaturated 
carbonyl compound and promotes deprotonation at the γ-site, providing a dienolate 
that can then add to an aldehyde, resulting in the vinylogous aldol product.  This is 
illustrated in the addition of crotonaldehyde to valeraldehyde (Scheme 2.1).
17
  This 
reaction is conducted by first combining the two aldehydes and ATPH, then 
selectively deprotonating the crotonaldehyde with a bulky base, LDA.  Deprotonation 
is disfavored at the proximal methylene of the valeraldehyde and preferentially occurs 
at the methyl group of the crotonaldehyde because it is sufficiently removed from the 
ATPH to be accessible, thereby providing a dienolate.  The aldol reaction then occurs 
at the distal (-) carbon of the dienolate due to steric hinderance at the proximal (-) 
carbon when the enolate is complexed to ATPH. 
Scheme 2.1.  Vinylogous Aldol Reaction of Crotonaldehyde and Valeraldehyde. 
 
Yamamoto and co-workers demonstrated that their newly developed ATPH-
mediated intermolecular vinylogous aldol reaction was effective using enolates 
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derived from conjugated aldehydes,
17
 ketones,
17,18
 and more significantly, esters.
18-20
  
Just as with conjugated aldehydes and ketones, reactions with conjugated esters 
proceed with high selectivity for addition at the sites distal to the ester and give high 
yields as shown in Table 2.1.  Intriguingly, polyenoates add to benzaldehyde at the 
site most distal to the ester even with extended conjugation in good to high yields 
(entries 4-7).  A piece of data that will prove to be interesting later in this section is 
that the straight-chain aldehyde, valeraldehyde, is not a practical electrophile using 
ester-derived enolates.  When reacted with methyl crotonate or E-methyl 2-methyl 
crotonate under Yamamoto’s conditions, the desired products were only formed in 
22% and 42% yields respectively (entries 3 and 10).  Yamamoto hypothesizes that 
valeraldehyde could suffer from competitive deprotonation at the α-carbon under the 
reaction conditions, and his hypothesis is supported by entries 2 and 9 where 
branching at the α-carbon to the aldehyde provided improved yields. 
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Table 2.1. Yamamoto Vinylogous Aldol Reaction with Conjugated Esters.
a
 
 
 Of very important note is the fact that both the conjugated ester and aldehyde 
must be complexed with ATPH in solution before the addition of base in order for the 
reaction to be successful.  Deviation from this protocol results in significantly lower 
yields and can result in the formation of homo-aldol products.
17,19
  This data lends 
itself to the notion that the ATPH-mediated vinylogous aldol reaction would also be 
successful in an intramolecular application, and it is from this notion that a project 
stemmed in our lab.  A previous graduate, Dr. Joseph Abramite, set out to 
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demonstrate that the ATPH-mediated vinylogous aldol reaction could be utilized 
intramolecularly to cyclize vinylogous ester-aldehydes and form large macrolides in a 
method that would be practical for the synthesis of natural products (Scheme 2.2).  
Dr. Abramite also embarked on demonstrating the possibility of remote asymmetric 
induction with chiral substrates. 
Scheme 2.2.  The Intramolecular Vinylogous Aldol Reaction. 
 
 Dr. Abramite was successful in forming 10-, 12-, and 14-membered 
macrolides via the intramolecular vinylogous aldol cyclization, and he found that the 
process indeed exhibits excellent remote stereocontrol with chiral acyclic substrates 
(Table 2.2).
6
  Ten-membered macrocycles were formed in very good yields (77-82%), 
with an interesting trend wherein increasing the steric bulk of the ring substituent 
resulted in greater preference for the E alkene in the product (entries 1 and 2).  
Twelve-membered macrolides were also produced in high yields (81-84%) and the E-
isomers were exclusively formed.  Just as in the case of reactions that formed 10-
membered macrolides, the 12-membered ring products are formed with excellent 
remote asymmetric induction with a >25:1 diastereomeric ratio at the newly formed 
hydroxyl group.  And most importantly for the application of this method to the total 
synthesis of arenolide, 14-membered macrolides were formed in the highest yields of 
all (88-90%).  Again, excellent remote stereocontrol was observed (~20:1), and only 
the E-alkene isomers were produced. 
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Table 2.2. ATPH-Mediated Intramolecular Vinylogous Aldol Reaction. 
 
 A major drawback of this method is that only non-enolizable aldehydes are 
effective electrophiles, a finding that is similar to that of Yamamoto in his 
intermolecular studies wherein enolizable aldehydes required -branching in order to 
provide high yields in reactions with ester enolates.  Dr. Abramite’s studies showed 
that substrates possessing enolizable aldehydes undergo either competitive 
enolization or enolate equilibration, and he was unable to find conditions to affect 
cyclization with ATPH.
21
  However, more recent studies by Jeff Gazaille, a current 
graduate student in the Sammakia lab, have resulted in the development of an even 
bulkier ATPH-based designer Lewis acid deriving from napthalene (11, Scheme 2.3).  
Initial studies with this new Lewis acid, which has been named ATNP, have shown 
that the intermolecular vinylogous aldol proceeds in high yields between methyl 
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crotonate and enolizable aldehydes (Scheme 2.3).  As discussed earlier, the ATPH-
mediated reaction between methyl crotonate and pentenal provided the desired 
product in 22% yield (Table 2.1, entry 10)
19
, and Yamamoto makes note that this 
aldehyde is not a viable electrophile.  In contrast, Mr. Gazaille has found that the 
ATNP-mediated reaction provides yields of 82% and 76% with butanal and hexanal 
respectively.  As shown in Scheme 2.3, straight-chain, α-branched, phenyl, and α,β-
unsaturated aldehydes all provide high yields of the desired product.  Further, the use 
of aldehydes bearing chirality at the -carbon provides the product in high yield 
(87%) and a diastereomeric ratio of 10:1 favoring the anti isomer.  These results 
significantly expand the scope of this reaction. 
Scheme 2.3.  ATNP-Mediated Intermolecular Vinylogous Aldol Reaction. 
 
 The success of the ATPH-mediated intramolecular vinylogous aldol reaction 
studies combined with these initial results of the ATNP-mediated intermolecular 
reaction provides good precedent for the application of this method to the key 
macrocyclic vinylogous aldol step for our synthesis of arenolide.  Our goal is to 
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demonstrate the utility of the intramolecular vinylogous aldol reaction, whether it be 
ATPH- or ATNP-mediated, in the complex setting of natural product synthesis.  The 
remainder of this chapter will present our current work towards this goal. 
 
2.4 A 1,5-Anti Aldol Approach to Arenolide 
 
As discussed in Section 2.2, we wished to build the main carbon skeleton of 
arenolide using a 1,5-anti aldol reaction between advanced ketone 3 and the simple 
aldehyde 7.  This reaction is well-precedented and was anticipated to set the 
stereochemistry at C9 and C13 with high diastereoselectivity.  Therefore, the first 
challenge that had to be met was the synthesis of ketone 3 (Figure 2.5). 
Figure 2.5.  Retrosynthesis of Intramolecular Vinylogous Aldol Precursor. 
 
Much of this path was paved previously by Dr. Aaron Cullen and it 
commenced with the protection of 3-butyn-1-ol to give tert-butyldimethylsilyl ether 
12 in quantitative yield (Scheme 2.4).  The next transformation was the highly 
efficient zirconium-assisted carboalumination of the terminal alkyne developed by 
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Negishi,
11,22
 the carbometallene intermediate of which was then trapped with 
paraformaldehyde to provide allylic alcohol 13.  No other alkene isomers were 
formed in this transformation.  In his initial investigation of this reaction, Dr. Cullen 
consistently obtained the desired alcohol along with the undesired formate ester 
analogue 13A in an equal mixture.  Fortunately, however, cleavage of the formate 
ester in the work-up via treatment with methanol and potassium carbonate gave the 
allylic alcohol in 79% yield uncontaminated by the formate. 
Scheme 2.4.  Synthesis of 13. 
 
Protection of the primary allylic alcohol with p-methoxybenzyl-
trichloroacetimidate provided the orthogonally protected diol 14 in 83% yield, at 
which point the TBS ether was selectively removed with TBAF (81%) and the 
resulting alcohol was then oxidized with Dess-Martin periodinane (Scheme 2.5).  
Although Dess-Martin periodinane is a somewhat expensive oxidant to use in large-
scale applications, such as at this early point in a total synthesis, other oxidation 
methods resulted in alkene migration from the C6-C7 position to C8-C9 in 
conjugation with the produced aldehyde.  To some extent, alkene migration even took 
place at room temperature during the reaction, and as such the reaction was optimally 
run at 0 °C overnight to provide the desired aldehyde, 16, in 64% yield. 
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Scheme 2.5.  Preparation of Aldehyde 16. 
 
2.4.1 Model Study  
 At this point in the synthesis it was concluded that a model substrate would be 
utilized to determine the viability of the key intramolecular vinylogous aldol 
macrocyclization.  Therefore, in an effort to obtain a model substrate as quickly as 
possible, the synthesis was streamlined and continued in a racemic fashion.  We had 
planned to set the stereochemistry at C9 using an asymmetric aldol reaction, but 
instead opted to build the carbon chain using an aldol reaction between acetone and 
aldehyde 16 thereby providing ketone 17 in racemic fashion and in 73% yield 
(Scheme 2.6).  This product would then have to undergo a selective 1,5-anti aldol 
reaction via the C12 enolate followed by acylation of the resulting alcohol, 
conversion of the C11 ketone to the exo-methylene, and finally, the intramolecular 
vinylogous aldol reaction.  We anticipated two potential obstacles to overcome in this 
route; first the 1,5-anti aldol reaction would have to proceed with high levels of 
stereoselectivity, second the vinylogous aldol reaction could suffer from undesired 
enolization at C8 to provide an aldehyde enolate.  We chose the protecting group at 
C9 such that we could minimize undesired enolization in the vinyolgous aldol 
reaction as we felt that this would be the more difficult obstacle.  We therefore 
decided to protect the hydroxyl group at C9 as a tert-butyldiphenylsilyl ether in hopes 
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that its size would prevent enolization proximal to C9 and provide the desired 
crotonate ester enolate (Figure 2.6).  The protecting group was thus installed with 
imidazole and TBDPSCl and gave 18 in quantitative yield. 
Scheme 2.6.  Synthesis of 1,5-Anti Aldol Ketone 18. 
 
Figure 2.6.  Rationale for the Use of a TBDPS Ether at C9. 
 
The 1,5-anti aldol reaction was then executed between ketone 18 and 
isovaleraldehyde by use of dibutylboron triflate and Hunig’s base.  The reaction 
proceeded in a very good yield of 92% but with a disappointing diastereomeric ratio 
of 2.3:1 (Scheme 2.7).  We were unable to separate the two diastereomers and 
deferred stereochemical assignment of the major diastereomer to a later time and both 
diastereomers were carried on throughout the synthesis.  The use of isovaleraldehyde 
is the only other major difference in the synthesis of our model substrate and the 
actual compound for the synthesis of arenolide, wherein we planned to use aldehyde 
21 in a similar 1,5-anti aldol reaction.  Silyl groups, such as our TBDPS ether, are 
known to negatively affect the diastereoselectivity of the 1,5-anti aldol reaction;
23-25
 
however, since our immediate goal was the synthesis of a model substrate, the 
71 
 
diastereomeric ratio was of no consequence at the time.  The resulting secondary 
alcohol was acylated with crotonic anhydride and stoichiometric DMAP to give 20 in 
a somewhat low yield of only 60%.  Other common conditions for this acylation were 
evaluated in efforts to increase the yield (crotonyl chloride, Hunig’s base and 
catalytic DMAP; crotonic anhydride, NEt3 and catalytic DMAP), however, these 
reactions suffered from either poor conversion to product or E/Z isomerization of the 
conjugated alkene.  Crotonic anhydride and DMAP consistently gave the cleanest 
acylations. 
Scheme 2.7.  Synthesis of Crotonic Ester 20. 
 
 The remaining steps to complete the model precursor that would be used to 
test our key intramolecular vinylogous aldol macrocyclization included converting 
the C11 ketone to a methylene group, deprotection of the primary p-methoxybenzyl 
(PMB) ether, and subsequent oxidation to the aldehyde.  Installation of the methylene 
group proved to be the most difficult transformation of those that remained.  Initial 
investigations began with Wittig olefination by use of methyltriphenylphosphonium 
bromide and KHMDS
26
, but the reaction conditions resulted in the elimination of the 
acyl group by crude 
1
H NMR (Scheme 2.8).  Modern Takai olefination conditions
27
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with dibromethane, TiCl4, zinc, catalytic lead chloride and TMEDA led to 
decomposition of starting material.  Gratifyingly, the original Takai olefination 
conditions
28,29
 with dibromomethane, TiCl4, zinc and catalytic lead chloride resulted 
in quantitative conversion to the product, 21, and an isolated yield of 48%.  As we 
were close to finishing the model substrate, this low yield was tolerated and the 
synthesis was continued; however, further studies would be necessary before 
applying this method in the total synthesis of arenolide.  Finally, PMB ether 
deprotection with DDQ (81%) and subsequent oxidation with Dess-Martin 
periodinane (84%) occurred uneventfully to provide the desired model precursor for 
our key intramolecular vinylogous aldol reaction. 
Scheme 2.8.  Completion of the Model Precursor 22. 
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 With macrolide precursor 22 in hand, we were now well poised to examine 
the viability of our key intramolecular vinylogous aldol reaction in cyclizing to the 
macrolide.  However, only 250 mg of this advanced substrate were obtained and 
therefore only two key reactions were performed, each on a 125 mg scale.  We opted 
against performing smaller-scale reactions due to difficulties handling the moisture 
sensitive reagents required in this reaction.  The first run was performed at -48 °C 
with 2.2 equivalents of ATPH and 2.5 equivalents of LTMP as the base (Scheme 2.9).  
After only 1.5 hours, the reaction appeared to be complete by TLC, and after work-up 
the crude 
1
H NMR revealed the presence of a new compound along with several 
impurities.  Flash column chromatography resulted in the isolation of material that 
appeared as a single spot by TLC; however, the material consisted of multiple 
compounds and the 
1
H NMR was too unclear to determine of this material contained 
the desired macrocycle.  The key vinylogous aldol reaction was therefore repeated 
using the same conditions, but at a lower temperature of -78 °C in hopes of 
minimizing the formation of by-products.  After 4.5 hours the reaction did not look 
complete by TLC, however, the TLC also did not seem to be changing further and so 
the reaction was worked-up.  The crude 
1
H NMR looked similar to that belonging to 
the first run of the reaction, and flash column chromatography again allowed for the 
isolation of a material that appeared as a single spot but which contained multiple 
compounds.  The components of this mixture were separated and isolated by high 
performance liquid chromatography (HPLC), which revealed the presence of four 
major components and several other minor ones.  This was not entirely unexpected 
given the number of possible diastereomers of the product.  Two of these four major 
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compounds were isolated in sufficient amount to analyze by NMR, and both of the 
compounds had 
1
H NMR spectra that were consistent with diastereomers of the 
desired macrolide.  High resolution mass spectrometry confirmed the composition of 
the compounds, providing good evidence that the key intramolecular vinylogous aldol 
reaction was a success! 
Scheme 2.9.  Intramolecular Vinylogous Aldol with Model Substrate 22. 
 
 The degree to which our key macrocyclization step was successful, however, 
was difficult to assess.  An accurate yield of all products could not be calculated, and 
the selectivity of the reaction could not be determined since the stereochemistry of the 
isolated diastereomers was not ascertained.  The crude 
1
H NMR spectra for both 
reaction trials were not very clean, and other undesired products were also isolated 
upon purification.  Therefore, while our key reaction required more troubleshooting, a 
lack of material prohibited further experiments.  An attempt at using our recently 
developed bulky Lewis acid, ATNP, would undoubtedly have been worthwhile; 
however, our studies surrounding ATNP had not yet begun at the time these trials 
were performed. 
 Still, the promising data that these initial trials produced gave us confidence 
that our desired macrocyclization would succeed in its application to the total 
synthesis of arenolide.  Since the model precursor for which we examined the key 
intramolecular vinylogous aldol reaction was very similar to that which would be 
75 
 
used en route to arenolide, we felt our results were sufficient precedent to undertake 
the total synthesis by use of the same key macrocyclization reaction. 
2.4.2 Arenolide Study 
Our efforts toward the first total synthesis of arenolide began with aldehyde 
16, the same compound that was used en route to our model substrate.  Subjection of 
aldehyde 16 to the asymmetric acetate aldol conditions developed in our lab 
(dichlorophenylborane, (‒)-sparteine and chiral N-acetyl thiazolidinethione 9) gave 
the desired S-isomer with >20:1 diastereoselectivity (Scheme 2.10).  The chiral 
auxiliary was then cleanly converted to the Weinreb amide in 79% over two steps 
with N,O-dimethylhydroxylamine hydrochloride, imidazole and triethylamine. 
Scheme 2.10.  Synthesis of Weinreb Amide 25. 
 
At this point in our synthesis it was necessary to make a decision in regards to 
which protecting group would be installed on the newly-formed hydroxyl at C9.  As 
mentioned earlier, silyl ethers are known to decrease the diastereoselectivity of the 
1,5-anti aldol reaction, and this was evidenced in the synthesis of our model substrate.  
Also discussed earlier, we hypothesized that a bulky protecting group would be best 
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in order to minimize aldehyde enolization in our key intramolecular vinylogous aldol 
reaction.  Finally, the group has to be orthogonal to the primary PMB ether at C5.  
Alkyl ethers such as PMB, benzyl, and methoxy methyl (MOM) groups are known to 
aid in the selectivity of the 1,5-anti aldol,
23-25
 and therefore our efforts first turned 
towards the installation of a bulky alkyl group, a triphenylmethyl (trityl) ether.  
Unfortunately, despite numerous attempts with many different conditions, the desired 
group could not be installed in good conversion or yield (Scheme 2.11).  Next, the 
introduction of a dimethoxybenzyl (DMB) ether was attempted, but just like the trityl 
group, the DMB group was also reluctant to go on. 
Scheme 2.11.  Failed Protecting Group Installations. 
 
Recently, Yamamoto and Yamaoka demonstrated the use of a very large 
tris(trimethylsilyl) ether in a highly selective 1,5-anti aldol reaction.
30
  As shown in 
Figure 2.7, the method involves the Lewis-acid-catalyzed attack of the TMS-enol 
ether of the β-alkoxy-protected ketone on the aldehyde.  The reaction is effective for 
straight-chain and branched ketones paired with various aldehydes, and provides the 
desired anti-aldol products in good yields and very high selectivities.  Yamamoto 
attributes the anti selectivity to a model wherein the alkyl group of the aldehyde 
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prefers to minimize its steric interaction with the methylene group of the enol ether 
and therefore adopts the transition-state leading to the 1,5-anti product (Figure 2.7).  
The steric bulk of the tris(TMS) protecting group along with the 1,5-anti selectivity 
that it imparts in the aldol reaction looked to be the perfect solution to our protecting 
group scheme.  Therefore, our efforts turned towards installation of the tris(TMS) 
group onto the hydroxyl group at C9. 
Figure 2.7. Yamamoto’s Supersilyl-Directed 1,5-Anti Aldol Reaction and Its 
Plausible Transition States. 
 
 Much to our dismay, the tris(TMS) ether could not be installed.  Various bases 
and conditions were evaluated; however, none provided the desired product in 
significant yield.  After many failed attempts, it was reasoned that since Yamamoto 
proposes a simple steric argument for the 1,5-anti stereoinduction outcome, a TBDPS 
ether may sufficiently mimic the steric bulk of the tris(TMS) to be successful under 
the same reaction conditions.  Therefore, Weinreb amide 25 was protected as a 
TBDPS ether, converted to the methyl ketone by subjection to methyllithium, and 
then the Lewis-acid-catalyzed 1,5-anti aldol reaction was attempted (Scheme 2.12).  
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Conversion to the TMS-enol ether was smooth; however, upon addition to the 
aldehyde followed by subjection to catalytic trifluoromethanesulfonimide (Tf2NH), 
the enol ether merely converted back to starting material ketone and none of the 
desired aldol adduct was isolated. 
Scheme 2.12.  Attempts at Yamamoto's Lewis-Acid-Catalyzed 1,5-Anti Aldol 
Reaction. 
 
 Once again we had returned to the same protecting group question as before: 
what group at C9 would promote diastereoselectivity for the 1,5-anti aldol reaction, 
but also prevent enolization of the aldehyde in the key intramolecular vinylogous 
aldol reaction?  After failing to install a group that would meet both criteria, the next 
plan of action became testing each criteria individually.  First, in efforts to meet steric 
bulk requirements, the 1,5-anti aldol reaction was examined with a TBDPS-protected 
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ether at C9 using the traditional boron-mediated conditions (Table 2.3).
7,31
  Although 
this reaction was utilized in the synthesis of our model substrate in which we 
observed poor diastereoselectivity, it was plausible that the reaction could be 
optimized.  Disappointingly, however, our examination with the TBDPS ether failed.  
Despite attempts with different borane sources, including the chiral 
chlorodiisopinocampheylborane, along with different aldehydes, the best observed 
diastereoselectivity was a mere 2:1. 
Table 2.3.  1,5-Anti Aldol Attempts With a TBDPS Ether at C9. 
 
Efforts were then exerted to individually test the remaining requirement: a 
protecting group that would promote selectivity in the 1,5-anti aldol reaction.  The 
alkyl protecting group, methoxy methyl (MOM) ether has significant precedence for 
promoting good 1,5-anti stereoinduction, and therefore it was installed and examined 
(Scheme 2.13).  Although this protecting group would most likely not be bulky 
enough to prohibit enolization of the aldehyde in the intramolecular vinylogous aldol 
reaction, it was at least orthogonal to the other protecting groups on the substrate and, 
in theory, it could be altered later in the synthesis, if need be.  Surprisingly, however, 
the MOM-protected β-alkoxy ketone 31 was reluctant to participate in the reaction.  
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Despite attempts with different boranes and amine bases, and even upon allowing 
reactions to warm to room temperature, still none of the desired aldol adduct was 
observed. 
Scheme 2.13.  1,5-Anti Aldol Attempts With a MOM Ether at C9. 
 
 At this point, we decided to re-evaluate our approach to the total synthesis of 
arenolide.  A different route that did not include the 1,5-anti aldol reaction to build 
the macrocycle precursor was necessary.  The design of such a route and our efforts 
towards its implementation in the synthesis of arenolide will be discussed in the 
following section. 
 
2.5 Second-Generation Approach to Arenolide 
 
In order to avoid a complete reworking of our synthetic strategy towards 
arenolide, focus was placed on a simple alternative to the 1,5-anti aldol reaction.  A 
straightforward solution was proposed involving a vinyl metal nucleophilic attack 
upon an enantiopure epoxide (Figure 2.8).  This is a very attractive route since 
circumventing the 1,5-anti aldol reaction evades the requirement of confirming the 
1,5-anti stereochemistry of the aldol product, and it avoids the late-stage 
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methylenation of the ketone at C11 which only proceeded in 48% yield on the model 
substrate (Scheme 2.8).  And as previously mentioned this route also prevented a 
complete revision of our strategy since it involves the same retrosynthetic precursors 
as our first-generation approach.  Aldehyde 16 from our original route would simply 
need to be converted to the vinyl halide, and then metal-mediated coupling with 
epoxide 34 would provide advanced precursor 6. 
Figure 2.8.  Second-Generation Retrosynthesis. 
 
 Model substrates 37 and 39 were used to assess the newly proposed route and 
were prepared beginning with protection of commercially available 3-pentyn-2-ol as 
the triisopropylsilyl (TIPS) ether with TIPS-Cl and imidazole (Scheme 2.14).  
Conversion of the terminal alkyne to the vinyl halide was first attempted by 
subjection of 36 to B-bromo-9-BBN.  Although the reaction conditions resulted in the 
clean addition of the bromine and BBN group across the alkyne, hydrolysis of the 
borane during the reaction work-up often resulted in decomposition of the product.  
After numerous attempts at troubleshooting failed to improve the reaction yield, 
conversion of the alkyne to the vinyl tin species 38 via the stannylcuprate was found 
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to be much more effective.
32-34
  Subsequent treatment of 38 with N-bromosuccinimide 
or N-iodosuccinimide gave the desired vinyl halide in 79% and 85% yield 
respectively over two steps. 
Scheme 2.14.  Preparation of Vinyl Halides 37 and 39. 
 
 Racemic epoxide 41 was then synthesized in 73% yield over two steps via 
benzyl protection of 3-buten-1-ol with sodium hydride and benzyl bromide, followed 
by epoxidation with mCPBA, and we were well poised to investigate our newly 
devised route (Scheme 2.15).  Initial epoxide-opening attempts with compounds 37 
and 39 were executed via lithium-halogen exchange with n-butyllithium followed by 
addition of epoxide 41 and BF3•etherate (Scheme 2.15).
35-37
  We were pleased to find 
that the reaction gave the desired product in good conversion in our initial runs, 
however, the reaction was eventually found to be irreproducible.  In many instances a 
nucleophilic halogen would open the epoxide to form the halohydrin, and often times 
a THF-derived polymer involving the epoxide could be isolated.  Various Lewis acids 
were screened including Ti(O
i
Pr)4, B(C6F5)3 and Cu(OTf)2, along with several 
different lithium sources and additives, however, conditions were not found to effect 
the desired transformation in sufficient yield. 
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Scheme 2.15.  Synthesis of Epoxide 41 and Failed Epoxide-Opening via Lithium-
Halogen Exchange of 37 and 39. 
 
 Cuprate addition of the vinyl halide to the epoxide was attempted next; 
lithium-halogen exchange via a lithium source followed by subjection to lithium-2-
thienylcyanocuprate formed the desired cuprate in situ, to which the epoxide was then 
added (Scheme 2.16).
38-40
  Unfortunately, however, this method also proved to be 
unsuccessful.  A test reaction involving reliable cuprate reaction partner, 2-
cyclohexen-1-one, was performed; however, no addition of the vinyl group to the β-
position (43) was observed, indicating that perhaps the desired cuprate was not 
forming.  This led to other reactions to test whether or not the lithium-halogen 
exchange was taking place.  Subjection of vinyl halides 37 and 39 to various lithium 
sources followed by trapping with TMS-Cl did not form the desired vinyl-TMS but 
instead merely resulted in the reduced vinyl halide, compound 44.  Conversion to 
compound 44 suggests that lithium-halogen exchange does take place; however, it is 
clear that the vinyl-metal species does not behave as desired, either because it gets 
protonated too quickly or for some other unknown reason. 
84 
 
Scheme 2.16.  Cuprate Addition and Lithium-Halogen Exchange Studies. 
 
Copper-mediated addition of the vinyl Grignard 45 to the epoxide was also 
examined (Scheme 2.17).  Somewhat discouragingly, the large amount of precedence 
for this approach strictly involves the formation of the Grignard on large scale, and 
therefore was anticipated to be difficult to apply to our synthesis.  Indeed, after much 
experimentation, formation of the vinyl Grignard reagent on small scale was 
unsuccessful.  Knochel’s highly reactive magnesium-insertion reagent, 46,41-43 was 
also investigated, however, this reagent was found to be very difficult to prepare and 
not useful for our purposes.  Variations of the reagent, compounds 47 and 48, were 
more readily prepared via formation of the Grignard reagent in the presence of LiCl.  
Disappointingly, both of these reagents led to the formation of their respective alkyl-
substituted vinyl compounds, 48 and 50, when added to vinyl bromide 37, prohibiting 
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any reaction with another electrophile.  Much to our dismay, it had become apparent 
that the vinyl nucleophilic attack upon an enantiopure epoxide would not be an 
effective method to prepare our desired product. 
Scheme 2.17.  Vinyl Grignard Studies. 
 
 Other metal-mediated couplings were then studied, beginning with a Stille 
coupling between the vinyl tin 38 and alkyl halides 53 and 54 (Scheme 2.18).  The 
alkyl halides were easily prepared via magnesium halide addition to the epoxide and 
then crotylation of the resulting halohydrin.  Unfortunately, when the coupling 
substrates were subjected to room temperature Stille conditions developed by Fu
44
 
([π-allylPdCl]2, [HP(
t
Bu)2Me]BF4 and Me4NF), no reaction took place with alkyl 
bromide 53 and an unidentified undesired product was formed with alkyl iodide 54.  
The same Stille conditions were used to attempt the coupling of 38 and commercially 
available epi-bromohydrin, however, the same unidentified undesired product as 
before was isolated. 
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Scheme 2.18.  Stille Coupling Reaction Studies. 
 
 Next, Hiyama couplings were investigated between cyclic silane 58 and alkyl 
iodide 54 along with epi-bromohydrin, as shown in Scheme 2.19.  Cyclic silane 58 
was synthesized in an unoptimized 31% yield over two steps from 4-pentyn-2-ol; the 
silyl group was added to the alcohol via triethylamine and catalytic DMAP and then a 
platinum-catalyzed intramolecular hydrosilylation reaction was utilized with 
H2PtCl6.
45-47
  This transformation was especially effective since the 5-exo product 
was formed exclusively with none of the undesired 6-endo product detected.  Again, 
room temperature Hiyama conditions pioneered by Fu
48,49
 were utilized (Pd(TFA)2 or 
PdBr2, [HP(
t
Bu)2Me]BF4 and TBAF), however, the reaction between 58 and vinyl 
iodide 54 gave no desired product.  Instead, the cyclic silane merely converted to the 
vinyl silane 59 and the iodide was substituted with a fluoride.  Similar results were 
seen in the attempted coupling of 58 and epibromohydrin; only the vinyl silane was 
present in the crude reaction mixture.  The vinyl silane was thought to be a possible 
Hiyama coupling partner, and so it was also subjected to Fu’s conditions with 
epibromohydrin.  Unfortunately, no reaction took place. 
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Scheme 2.19.  Hiyama Coupling Reaction Studies. 
 
 Many other similar sp
2
-sp
3
 couplings have been accomplished in the context 
of total synthesis, most of which are executed via the metal-mediated opening of an 
epoxide which failed with our system.
36,37,50
  The alkoxy group α- to the halide on the 
electrophile made our system more difficult to attempt other precedented sp
2
-sp
3
 
couplings, specifically because our substrates were strictly defined, and therefore 
limited, in their reactivities.  We could not invert their reactivities, e.g., make the 
vinyl halide the electrophile and the α-alkoxy substrate the nucleophile, since any 
metal intermediates of the α-alkoxy moiety would quickly eliminate to give the 
unreactive terminal alkene.  Fortunately, a clever idea surfaced wherein the α-alkoxy 
group is circumvented, expanding the substrates’ possible reactivities once again.  
The suggestion involved the utilization of a diboration reaction
51-57
 of the terminal 
alkene from which our epoxide was originally synthesized (Scheme 2.20).  After 
selectively functionalizing the diborane product at the terminal position via a B-alkyl 
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Suzuki coupling with the vinyl halide, the remaining secondary borane could then 
easily be oxidized to an alcohol.  In addition, the desired stereochemistry of the 
eventual alcohol would be set in the diboration step.
51,57
  The idea enabled the 
inversion of reactivities between the desired substrates and was deemed a promising 
and even more efficient alternative to the 1,5-anti aldol reaction, therefore, it was 
immediately investigated. 
Scheme 2.20.  Proposed Diboration, B-Alkyl Suzuki Coupling, then Oxidation. 
 
 Just as with the previously prepared epoxide, synthesis of the diboronic ester 
began with the protection of 3-buten-1-ol as the TBS ether.  Asymmetric diboration 
of the terminal alkene by use of bis(pinacolato)diboron, a novel TADDOL ligand and 
Pt2(dba)3 cleanly gave the desired bis(boronic ester) 64 in 71% yield.
57
  Gratifyingly, 
our initial B-alkyl Suzuki coupling attempt between 64 and model vinyl iodide 39 
with Pd(PPh3)4 and thallium ethoxide
58-61
 provided the desired product and after 
oxidizing the remaining secondary boronic ester to the alcohol could be isolated in 
62% yield. 
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Scheme 2.21.  Successful Implementation of the Diboration, B-Alkyl Suzuki 
Coupling and Oxidation Sequence. 
 
After the lengthy amount of failure we had endured beginning with the lack of 
diastereoselectivity in the 1,5-anti aldol reaction and continuing into the failed metal-
mediated couplings, we had finally devised a very promising route to the key 
intramolecular vinylogous aldol precursor and immediately set upon applying that 
route to the synthesis of arenolide.  Beginning with an intermediate from our 1,5-anti 
aldol route, Weinreb amide 25 was protected as the TIPS ether in 95% yield (Scheme 
2.22).  Next, conversion of the Weinreb amide to the aldehyde, 67, via DIBAL-H 
reduction was smooth and gave the desired product in 92% yield.  Initial attempts at 
installing the alkyne were performed by use of the Ohira-Bestmann reagent
62
; 
however, this method consistently gave only 40% yield of the desired product, 69.  
Application of the Corey-Fuchs protocol,
63,64
 which called for conversion of the 
aldehyde to the dibromo-alkene (68) followed by elimination to the alkyne, gave 
superior results and provided the terminal alkyne in 80% yield over two steps.  And 
gratifyingly, formation of the vinyl iodide was smooth via the method developed 
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earlier with our model alkyne 36 (Scheme 2.14).  Copper-mediated addition of 
tributyltin hydride across the alkyne followed by conversion of the crude vinyl tin 70 
to the iodide with N-iodosuccinimide cleanly afforded the desired product 71 over 
two steps in 83% yield. 
Scheme 2.22.  Preparation of Vinyl Iodide 71. 
 
 We were now poised to attempt the B-alkyl Suzuki coupling between the 
enantiopure substrates 71 and bis(boronic ester) 65 with hopes of finally overcoming 
all of the obstacles associated with developing a route alternative to that which 
includes the 1,5-anti aldol reaction.  In the event, conditions that had previously been 
successfully optimized for the coupling of model substrate 39 and the same 
bis(boronic ester) 65 were utilized; however, none of the desired product was formed 
(Scheme 2.23).  Instead, the reaction produced a complex mixture of alkene-
containing products which could not be identified.  Alternative conditions were 
studied, including different palladium catalysts, bases and solvents, but unfortunately 
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none of the coupling product could be isolated.  However, time constraints limited an 
exhaustive survey of the many different combination of Suzuki coupling reagents, 
and therefore this route to the key vinylogous aldol precursor, and ultimately the 
arenolide core, still holds a great deal of potential.  Nonetheless, for that potential to 
be realized, conditions which successfully promote this B-alkyl Suzuki coupling 
between 71 and 65 would first need to be identified.  
Scheme 2.23.  Failed B-Alkyl Suzuki Coupling Between 71 and 65. 
 
 
2.6 Conclusion and Future Direction 
 
In conclusion, two main approaches toward the macrocyclic core of arenolide 
have been thoroughly studied.  The first approach culminated with the completion of 
a model substrate upon which our key intramolecular vinylogous aldol reaction was 
attempted.  Gratifyingly, the desired macrocycle was formed and isolated; however, 
the yield and diastereoselectivity of the reaction was not determined.  Nonetheless, it 
is apparent that this key reaction holds a significant amount of potential and now 
some precedent for its success in the total synthesis of arenolide, especially 
considering our lab’s recent development of the bulkier and more versatile Lewis 
Acid, ATNP.  Its use should undoubtedly provide the macrocycle in good yield and 
stereoselectivity. 
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This original approach to the core of arenolide utilized a 1,5-anti aldol 
reaction which was found to lack diastereoselectivity when applied to the total 
synthesis.  Therefore, a re-working of our synthetic plan was required and a second-
generation approach was developed with a focus on alternative methods to produce 
the 1,5-anti relationship between the alkoxy groups at C9 and C13 with the exo-
methylene group at C11.  Extensive studies on metal-mediated couplings to produce 
the desired moiety were performed, and success was initially found via use of a B-
alkyl Suzuki reaction using a model alkene and a diboronate substrate.  However, this 
coupling failed when applied to the substrate required for the total synthesis. 
Future work in this project must clearly focus on the completion of the total 
synthesis of arenolide.  Upon identification of conditions that will successfully couple 
vinyl halide 71 and diboronate 65, mere acylation, PMB deprotection and subsequent 
oxidation reactions remain to arrive at the intramolecular vinylogous aldol precursor, 
76 (Scheme 2.24).  The key macrocyclic reaction was shown to be effective on a 
model substrate described in this chapter (22, Scheme 2.9), and with our lab’s newly 
developed and bulkier Lewis acid, ATNP, this key transformation is highly 
anticipated to be successful. 
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Scheme 2.24.  Key Vinylogous Aldol Macrocyclization En Route to the Total 
Synthesis of Arenolide. 
 
With a direct and well-studied route which holds a significant potential in 
completing the macrocyclic core of arenolide, as that described in this chapter, 
attention must now be refocused on the synthesis of the diastereomeric side chains 
and their coupling to the natural product’s core.  The absolute and relative 
stereochemistries of the hydroxyl groups at C19 and C21 remain undetermined; 
therefore, all four diastereomers of the side chain must be synthesized and then 
coupled to the macrocyclic core in order for comparison of known spectral data and 
determination of arenolide’s absolute stereochemistry to take place (Figure 2.9).  
Thus, the side chain synthesis requires flexibility in order to construct all of the 
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diastereomers, and all of the side chains should ideally intercept at a common 
intermediate in order to be efficiently incorporated into the total synthesis.  
Retrosynthetically, the access point for each side chain stereoisomer could be through 
a B-alkyl Suzuki coupling reaction between the exo-macrocyclic vinyl halide of 78 
and respective side chain borane 79.  Each borane side chain could be built via a 9-
BBN hydroboration reaction of ethylidene acetal 81.  Gratifyingly, Dr. Aaron Cullen 
has studied the synthesis of each possible side chain diastereomer.
65
  In his work he 
determined that all four stereoisomers could be prepared either via an asymmetric 
allylation of a β-alkoxy aldehyde 82 or a selective reduction of allylic ketone 83, and 
he found that both 82 and 83 can be synthesized from poly[(R)-3-hydroxybutyric 
acid]. 
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Figure 2.9.  Endgame for the Total Synthesis of Arenolide. 
 
 Dr. Cullen efficiently built both the (R,R)- and (S,S)-isomers of 87 via similar 
routes commencing with the depolymerization and esterification of poly[(R)-3-
hydroxybutyric acid] (Scheme 2.25).
66
  The C21 hydroxyl group of the (R,R)-isomer 
was then protected as an acetal in 72% yield over the two steps and with 98% ee, 
followed by DIBAL-H reduction of the C19 ester to the aldehyde gave 86 in 95% 
yield.  An asymmetric allylation method developed by our lab
65
 was then utilized to 
give exclusively the anti side chain isomer, (R,R)-87, in 76% yield. 
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Scheme 2.25.  Preparation of (R,R)-87. 
 
 The (S,S)-isomer was prepared in the same method as its enantiomer, 
however, after depolymerization and esterification of poly[(R)-3-hydroxybutyric 
acid], the C21 stereocenter was inverted by conversion of the hydroxyl group to a 
mesylate followed by the SN2 addition of water which, upon work-up, gave (S)-3-
hydroxybutyrate 84 in 75% yield and 94% ee (Scheme 2.26).  While the formation of 
methyl crotonate may be expected under these reaction conditions via elimination of 
the secondary mesyl group, gratifyingly, none of this undesired product was formed. 
Scheme 2.26.  Preparation of (S,S)-87. 
 
 With completion of the synthesis of the anti-stereoisomers, Dr. Cullen’s focus 
was then direction towards the synthesis of the syn-enantiomers.  Conversion of (R)-
84 to the Weinreb amide in 85% followed by subsequent addition of allylmagnesium 
bromide gave α-alkoxy ketone 89 in 87% yield.  A stereoselective reduction of the 
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ketone, e.g., the Narasaka-Prasad reduction protocol,
67
 would then provide the 
requisite (S,R)-syn-diol in a precedented fashion.  And if this sequence is successful, 
the same method would be utilized to build the (R,S)-isomer. 
Scheme 2.27.  Preparation of (S,R)-91 and (R,S)-91. 
 
 As discussed earlier, endgame of the total synthesis of arenolide would consist 
of conversion of the cyclized macrolide to exocyclic vinyl halide 95 via protection of 
the secondary alcohol and selective reduction of the α,β-unsaturated ester olefin 
(Scheme 2.28).  Installation of the vinyl halide would proceed via the corresponding 
alkyne (93).  This would be prepared by the selective deprotection of the TBS-ether 
of 77, oxidation of the subsequent alcohol to the aldehyde, and then conversion to the 
alkyne using the Ohira-Bestmann reagent
62
 or the Corey-Fuchs method.
64
  The alkyne 
could then be converted to the vinyl halide by the sequence already used in our 
synthesis of the macrocyclic precursor: copper-mediated tributyltin hydride addition 
across the alkyne and then installation of the iodide by subjection to N-
iodosuccinimide. 
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Scheme 2.28.  Completion of the Macrocyclic Core. 
 
 After hydroboration of all four of the diastereomeric ethylidene acetal side 
chain alkenes, coupling to the macrocyclic core by use of a B-alkyl Suzuki reaction 
would be studied (Scheme 2.29).  After coupling, global deprotection would provide 
all of the stereoisomers of arenolide which are to be analyzed in order to determine 
the natural product’s absolute stereochemistry and better assess its bioactivity.  It is 
possible that in assaying all four of the stereoisomers, one may display more potent 
activity than the natural product and possibly provide significant structure-activity 
relationship data.  Current efforts are underway to complete the total synthesis of 
arenolide, determine its absolute stereochemistry, and assess its bioactivity as well as 
that of its stereoisomers. 
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Scheme 2.29.  Completion of Arenolide. 
 
 
2.7 Experimental Information 
 
General Information: 
 All reactions were conducted in oven-dried glassware under a dry nitrogen 
atmosphere.  Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled over 
sodium benzophenone ketyl under N2.  Dichloromethane (CH2Cl2), 
diisopropylethylamine (
i
Pr2NEt), triethylamine (NEt3), isovaleraldehyde, 
dibromomethane, and toluene were distilled over CaH2 and under N2.  
Diisopropylamine (
i
Pr2NH) was distilled over sodium and under N2.  Titatinium(IV) 
chloride was distilled over copper turnings and under N2.   N,N-dimethylformamide 
(DMF) was distilled over CaH2 and under reduced pressure (~2 torr).   Acetone was 
distilled over ground CaSO4 and under N2.  3-Butyn-1-ol, imidazole, tert-
butyldimethylsilylchloride (TBS-Cl), cyclohexane, trimethylaluminum (2.0 M in 
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hexanes), prilled paraformaldehyde (methanol-free), pyridinium p-toluene sulfonate 
(PPTS), tetrabutylammonium fluoride (TBAF; 1.0 M in tetrahydrofuran), n-
butyllithium (solution in hexanes), methyllithium (solution in Et2O), tert-
butyldiphenylsilylchloride (TBDPS-Cl), dibutylboron triflate, crotonic anhydride, 4-
(dimethylamino)pyridine (DMAP), lead(II) chloride, 2,3-dichloro-5,6-dicyano-p-
benzoquinone (DDQ), 2,6-diphenylphenol, 2,2,6,6-tetramethylpiperidine, 
dichlorophenyl borane (97%), (‒)-sparteine, N,O-dimethyl hydroxylamine, 
chlorotrimethylsilane, chloromethyl methyl ether, sodium hydride (60% in mineral 
oil), benzyl bromide, triisopropylchlorosilane (TIPS-Cl), tributyltin hydride, copper(I) 
cyanide, N-bromosuccinimide (NBS), N-iodosuccinimide (NIS), magnesium, iodine, 
4-pentyn-2-ol, chlorodiisopropylsilane, chloroplatinic acid hexahydrate, isopropanol, 
3-buten-1-ol, bis(pinacolato)diboron, dioxane, tetrakis(triphenylphosphine)palladium,  
thallium ethoxide, diisobutylaluminum hydride (DIBAL-H, 1.0 M solution in 
hexanes), carbon tetrabromide, and triphenylphosphine were purchased from Aldrich 
and used without further purification.  Zirconocene dichloride was purchased from 
Aldrich and heated to 80 °C under reduced pressure for 2 h prior to use.  Zinc dust 
was activated prior to use by being placed on a Buchner funnel and then washed with 
5% HCl several times, followed by thorough washings with DI H2O, methanol, and 
Et2O.  3-Chloroperbenzoic acid (mCPBA) was purified prior to use by dissolving in 
CH2Cl2 (~1g/30mL), washing with pH=7.5 1M phosphate buffer (3x100 mL) and 
brine, drying over MgSO4, filtering through Celite and concentrating under reduced 
pressure.  Flash column chromatography was performed using 60 Å silica gel (32-63 
μm).  1H NMR spectra were obtained at 500 MHz or 400 MHz and 13C NMR spectra 
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at 125 or 100 MHz in CDCl3 as indicated.  Chemical shifts are reported in ppm 
referenced to CHCl3 (7.24 ppm for 
1
H) and CDCl3 (77.0 ppm for 
13
C).  IR spectra 
were recorded as thin films on NaCl plates.  Exact mass was obtained using 
electrospray ionization in positive ion mode (M+H, or M+Na, or M+Li) or in 
negative ion mode (M+Cl) as indicated. 
(But-3-ynyloxy)(tert-butyl)dimethylsilane (12): 
 
 To a solution of 3-butyn-1-ol (10.0 g, 140. mmol, 1.0 equiv) in CH2Cl2 (180 
mL) was added imidazole (12.0 g, 170 mmol, 1.2 equiv) followed by tert-
butyldimethylsilylchloride (26.0 g, 160 mmol, 1.1 equiv) both upon brief exposure to 
air, at which point a white precipitate formed.  After being allowed to stir overnight, 
the suspension was quenched with saturated NaHCO3 (20 mL).  The mixture was then 
diluted with DI H2O and transferred to a separatory funnel. The aqueous layer was 
extracted with CH2Cl2 (2×15 mL) and the combined organics were dried over 
MgSO4, filtered through Celite, and concentrated under reduced pressure to give the 
known ether 12 as a pale yellow oil (26.0 g, 140 mmol, ~99%). 
 IR (cm
-1
): 3315, 2956, 2930, 2885, 2858, 1472, 1464.  
1
H NMR (500 MHz, 
CDCl3): δ 3.72 (t, J = 7.1, 2H), 2.38 (td, J = 7.1, 2.7, 2H), 1.94 (t, J = 2.7, 1H), 0.88 
(s, 9H), 0.08 (s, 6H).
13
C NMR (75 MHz, CDCl3) δ 81.53, 69.26, 61.73, 25.88, 22.84, 
18.33, -5.30. 
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(E)-5-(tert-Butyldimethylsilyloxy)-3-methylpent-2-en-1-ol (13): 
 
 To a solution of pre-dried zirconocene dichloride (22.0 g, 76.0 mmol, 2.0 
equiv) in CH2Cl2 (191 mL) was added trimethylaluminum (115 mL, 2.0 M solution in 
hexanes, 229 mmol, 6.0 equiv).  The solution was stirred for 15 min, and then cooled 
(0 °C) and DI H2O (0.690 mL, 38.0 mmol, 1.0 equiv) was carefully added by syringe.  
Caution: Water must be added slowly as rapid gas evolution occurs!  The pale-
yellow solution was allowed to stir for 0.5 h at 0 °C, then alkyne 12 (7.00 g, 38.0 
mmol, 1.0 equiv) was added via cannula.  The solution was allowed to warm to room 
temperature and stirred for 24 h, then re-cooled to 0 °C at which time prilled 
paraformaldehyde (5.70 g, 191 mmol, 5.0 equiv) was added by a powder addition 
funnel.  The resulting suspension was allowed to stir at room temperature for 2 days 
and then was quenched with methanol.  The addition of methanol resulted in the 
formation of a gel, which can be homogenized by the addition of Et2O and saturated 
K2CO3 followed by rapid stirring for 1.5 h.  The milky-white solution was then 
filtered through Celite, diluted with CH2Cl2, and then transferred to a separatory 
funnel.  The aqueous layer was extracted with CH2Cl2 (4×20 mL), and the combined 
organics were dried over MgSO4, filtered through Celite, and concentrated under 
reduced pressure to give a yellow oil.  Purification by flash column chromatography 
on silica gel (5:1 hexanes/ethyl acetate) gave the known alcohol 13 as a clear, pale-
yellow oil (6.90 g, 30 mmol, 79%). 
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 IR (cm
-1
): 3343, 2955, 2929, 2857, 1412.  
1
H NMR (500 MHz, CDCl3): δ 5.43 
– 5.40 (m, 1H), 4.13 (d, J = 6.9, 2H), 3.67 (t, J = 7.0, 2H), 2.22 (t, J = 7.0, 2H), 2.15 
(br s, 1H), 1.67 (s, 3H), 0.86 (s, 9H), 0.02 (s, 6H).  
13
C NMR (75 MHz, CDCl3) δ 
136.92, 125.17, 62.04, 59.33, 42.77, 25.92, 18.32, 16.68, -5.30. 
(E)-tert-Butyl(5-(4-methoxybenzyloxy)-3-methylpent-3-enyloxy)dimethylsilane 
(14): 
 
To a cooled (0 °C) solution of alcohol 13 (2.60 g, 11.0 mmol, 1.0 equiv) in 2:1 
cyclohexane/CH2Cl2 (18 mL/9 mL) was added p-methoxybenzyl 
trichloroacetimidate
68
 (4.70 g, 17.0 mmol, 1.5 equiv), followed by pyridinium p-
toluene sulfonate (0.284 g, 1.1 mmol, 0.1 equiv).  The solution was stirred at 0 °C for 
15 min, and then allowed to warm to room temperature.  After 20 h, the reaction was 
quenched with half-saturated NaHCO3 (10 mL) and transferred to a separatory funnel.  
The aqueous layer was extracted with CH2Cl2 (3×10 mL) and the combined organics 
were dried over MgSO4, filtered through Celite, and concentrated under reduced 
pressure.  The crude material was then diluted with hexanes and a white precipitate 
crashed out of solution.  This suspension was filtered through Celite and the filtrate 
was concentrated under reduced pressure.  Purification by flash column 
chromatography (12:1 hexanes/ethyl acetate) gave the bis-protected ether 14 as a 
yellow oil (3.30 g, 9.4 mmol, 83%). 
IR (cm
-1
): 2954, 2929, 2856, 1613, 1513.  
1
H NMR (500 MHz, CDCl3): δ 7.27 
– 7.23 (m, 2H), 6.89 – 6.82 (m, 2H), 5.38 – 5.34 (m, 1H), 4.41 (s, 2H), 3.97 (d, J = 
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6.7, 2H), 3.78 (s, 3H), 3.67 (t, J = 7.1, 2H), 2.23 (t, J = 7.1, 2H), 1.64 (s, 3H), 0.86 (s, 
9H), 0.02 (s, 6H).  
13
C NMR (75 MHz, CDCl3) δ 159.12, 137.37, 130.63, 129.39, 
122.75, 113.73, 71.67, 66.23, 62.17, 55.27, 42.87, 25.94, 18.33, 16.94, -5.28. 
(E)-5-(4-Methoxybenzyloxy)-3-methylpent-3-en-1-ol (15): 
 
To a cooled (0 °C) solution of bis-protected ether 14 (3.30 g, 9.4 mmol, 1.0 
equiv) in THF (47 mL) was added TBAF (14.0 mL, 1 M solution in THF, 14 mmol, 
1.5 equiv) slowly via syringe.  The reaction was allowed to slowly warm to room 
temperature and after 1.5 h was quenched with DI H2O (10 mL) and saturated NH4Cl 
(10 mL).  After stirring for 5 min, the mixture was transferred to a separatory funnel 
and the aqueous layer was extracted with CH2Cl2 (3×15 mL).  The combined organics 
were washed with brine (1×15 mL), dried over MgSO4, filtered through Celite, and 
concentrated under reduced pressure.  Purification by flash column chromatography 
on silica gel (1:1 hexanes/ethyl acetate) provided the desired alcohol 15 (1.80 g, 7.50 
mmol, 81%) as a colorless oil. 
IR (cm
-1
): 3405, 2935, 1612, 1586.  
1
H NMR (500 MHz, CDCl3): δ 7.28 – 
7.21 (m, J = 9.1, 2H), 6.89 – 6.81 (m, 2H), 5.46 (t, J = 6.7, 1H), 4.42 (s, 2H), 3.99 (d, 
J = 6.7, 2H), 3.78 (s, 3H), 3.72 – 3.65 (m, 2H), 2.28 (t, J = 6.3, 1H), 1.65 (s, 3H).  13C 
NMR (75 MHz, CDCl3): δ 159.19, 136.59, 130.43, 129.44, 123.82, 113.78, 71.95, 
66.15, 60.24, 55.27, 42.57, 16.37. 
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(E)-5-(4-Methoxybenzyloxy)-3-methylpent-3-enal (16): 
 
 To a cooled (0 
o
C) solution of alcohol 15 (0.23 g, 0.952 mmol, 1.0 equiv) in 
CH2Cl2 (9.5 mL) was added Dess-Martin periodinane
69
 (0.61 g, 1.43 mmol, 1.5 
equiv) in one portion. The resulting white suspension was kept at 0 °C and allowed to 
stir overnight.  Then the mixture was filtered through Celite, quenched with saturated 
1:1 Na2S2O3/NaHCO3 (10 mL), and allowed to stir for at least 2 h at room 
temperature.  The crude mixture was then transferred to a separatory funnel and the 
organic layer was washed with saturated NaHCO3 (2×7 mL).  The combined aqueous 
layers were then extracted with CH2Cl2 (3×7 mL) and the combined organics were 
then dried over MgSO4, filtered through Celite, and concentrated under reduced 
pressure.  Alkene migration was found to take place during purification by flash 
column chromatography on silica gel (CH2Cl2), therefore, the crude material was 
used directly in the next reaction without further purification. 
1
H NMR (500 MHz, CDCl3): δ 9.63 (t, J = 2.3, 1H), 7.28 – 7.24 (m, 2H), 6.88 
– 6.84 (m, 2H), 5.56 – 5.52 (m, 1H), 4.43 (s, 2H), 4.03 (d, J = 6.6, 2H), 3.78 (s, 3H), 
3.09 (d, J = 1.4, 2H), 1.68 (s, 3H). 
(E)-4-Hydroxy-8-(4-methoxybenzyloxy)-6-methyloct-6-en-2-one (17): 
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 To a cooled (-78 °C) solution of diisopropylamine (1.64 mL, 11.5 mmol, 1.4 
equiv) in THF (25 mL) was added n-butyllithium (7.9 mL, 1.46 M solution in 
hexanes, 1.4 equiv) dropwise via syringe.  The reaction was allowed to stir for 15 
mins, and then acetone (0.785 mL, 10.7 mmol, 1.3 equiv) was added via syringe.  
After stirring for another 30 mins at -78 °C, aldehyde 16 (1.93 g, 8.22 mmol, 1.0 
equiv) in a small amount of THF was added to the reaction mixture via cannula.  The 
reaction was allowed to stir for 40 mins and then was quenched by the addition of 
saturated NH4Cl (20 mL).  The solution was allowed to warm to room temperature 
and was then transferred to a separatory funnel.  The aqueous phase was extracted 
with ethyl acetate (3×10 mL) and then the combined organics were dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  Purification 
by flash column chromatography (1:1 hexanes/ethyl acetate) provided the desired 
aldol adduct 17 (1.75 g, 6.0 mmol, 73%). 
1
H NMR (500 MHz, CDCl3): δ 7.26 – 7.22 (m, 3H), 6.88 – 6.83 (m, 2H), 5.45 
(t, J = 6.6, 1H), 4.42 (s, 2H), 4.23 – 4.13 (m, 1H), 4.04 – 3.95 (m, 2H), 3.78 (s, 3H), 
2.80 (d, J = 3.1, 1H), 2.64 – 2.47 (m, 2H), 2.22 (dd, J = 13.6, 7.7, 1H), 2.18 – 2.09 
(m, 4H), 1.66 (s, 3H). 
(E)-4-(tert-Butyldiphenylsilyloxy)-8-(4-methoxybenzyloxy)-6-methyloct-6-en-2-
one (18): 
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 To a solution of 17 (1.35 g, 4.62 mmol, 1.0 equiv) in DMF (15.4 mL) was 
added imidazole (1.57 g, 23.1 mmol, 5.0 equiv) upon brief exposure to air.  Then tert-
butydiphenylsilylchloride (3.0 mL, 11.5 mmol, 2.5 equiv) was added dropwise via 
syringe, upon which a white precipitate formed.  The reaction was allowed to stir 
overnight and was then quenched by the addition of saturated NaHCO3 (15 mL).  The 
crude mixture was transferred to a separatory funnel and the aqueous phase was 
extracted with ethyl acetate (3×10 mL).  The combined organics were dried over 
MgSO4, filtered through Celite and then concentrated under reduced pressure.  
Purification by flash column chromatography (6:1 hexanes/ethyl acetate) gave the 
protected product 18 (2.40 g, 4.52 mmol, 98%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.70 – 7.61 (m, J = 6.8, 0.9, 4H), 7.45 – 7.31 
(m, 6H), 7.23 – 7.17 (m, 2H), 6.88 – 6.80 (m, 2H), 5.28 (t, J = 6.6, 1H), 4.34 (s, 2H), 
4.34 – 4.28 (m, 1H), 3.85 (d, J = 6.6, 2H), 3.78 (s, 3H), 2.59 – 2.42 (m, 2H), 2.20 – 
2.05 (m, 2H), 2.01 (s, 3H), 1.25 (s, 3H), 1.00 (s, 9H). 
(E)-8-(tert-Butyldiphenylsilyloxy)-4-hydroxy-12-(4-methoxybenzyloxy)-2,10-
dimethyldodec-10-en-6-one (19): 
 
 To a cooled (-78 °C) solution of 18 (2.40 g, 4.52 mmol, 1.0 equiv) and 
diisopropylethylamine (1.2 mL, 7.01 mmol, 1.55 equiv) in Et2O (45 mL) was added 
dibutylboron triflate (6.33 mL, 1.0 M solution in toluene, 6.33 mmol, 1.4 equiv) 
dropwise via syringe.  The reaction was allowed to stir for 30 mins and then a 1.0 M 
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solution of isovaleraldehyde (6.33 mL, 6.33 mmol, 1.4 equiv) in THF was added 
slowly via syringe pump over 1 h.  After being allowed to stir for 2 h at -78 °C, the 
reaction was allowed to warm to 0 °C and then 32 mL of a 1:6 pH=7 buffer/MeOH 
solution was added via syringe.  Next, 13.7 mL of a 1:2 30% H2O2/MeOH solution 
was added to the reaction via syringe.  Finally, the reaction was then allowed to warm 
to room temperature and stir for 1 h, at which point it was transferred to a separatory 
funnel.  The aqueous phase was extracted with Et2O (2×10 mL) and then the 
combined organics were washed with saturated NaHCO3 (1×10 mL) and brine (1×10 
mL).  The organics were then dried over MgSO4, filtered through Celite and then 
concentrated under reduced pressure.  Purification by flash column chromatography 
(5:1 hexanes/ethyl acetate) gave the desired aldol product 19 (2.56 g, 4.14 mmol, 
92%). 
 Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3): δ 7.72 – 7.57 (m, 4H), 7.44 – 7.32 (m, 6H), 
7.22 – 7.16 (m, 2H), 6.88 – 6.77 (m, 2H), 5.33 – 5.22 (m, 1H), 4.39 – 4.24 (m, 3H), 
4.03 – 3.93 (m, 1H), 3.84 (d, J = 6.6, 2H), 3.77 (s, 3H), 2.98 (d, J = 3.5, 0.2H, minor 
diastereomer), 2.93 (d, J = 3.3, 0.6H, major diastereomer), 2.59 – 2.23 (m, 4H), 2.23 
– 2.06 (m, 2H), 1.79 – 1.64 (m, 1H), 1.43 – 1.31 (m, 1H), 1.26 – 1.21 (m, 3H), 1.03 – 
0.96 (m, 10H), 0.86 (d, J = 6.6, 6H). 
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(E)-((E)-8-(tert-Butyldiphenylsilyloxy)-12-(4-methoxybenzyloxy)-2,10-dimethyl-
6-oxododec-10-en-4-yl) but-2-enoate (20): 
 
 To a cooled (0 °C) solution of 19 (2.42 g, 3.93 mmol, 1.0 equiv) and CH2Cl2 
(39 mL) was added crotonic anhydride (1.2 mL, 7.86 mmol, 2.0 equiv), followed by 
DMAP (0.720 g, 5.89 mmol, 1.5 equiv) upon brief exposure to air.  The reaction was 
allowed to stir at 0 °C for 3 h and was then quenched the addition of saturated 
NaHCO3 (30 mL).  The crude mixture was then transferred to a separatory funnel and 
the aqueous phase was extracted with CH2Cl2 (3×10 mL) and the combined organics 
were washed with DI H2O (1×10 mL), dried over MgSO4, filtered through Celite and 
then concentrated under reduced pressure.  Purification by flash column 
chromatography (9:1 hexanes/ethyl acetate) provided the acylated product 20 (1.61 g, 
2.36 mmol, 60%). 
 Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3): δ 7.72 – 7.64 (m, 4H), 7.46 – 7.32 (m, 6H), 
7.25 – 7.19 (m, 2H), 6.97 – 6.89 (m, 1H), 6.89 – 6.83 (m, 2H), 5.82 – 5.72 (m, 1H), 
5.37 – 5.24 (m, 2H), 4.40 – 4.28 (m, 4H), 3.87 (d, J = 6.6, 2H), 3.80 (s, 3H), 2.73 – 
2.41 (m, 4H), 2.20 – 2.08 (m, 2H), 1.90 – 1.80 (m, 3H), 1.63 – 1.46 (m, 2H), 1.34 – 
1.21 (m, 4H), 1.00 (s, J = 8.6, 9H), 0.93 – 0.85 (m, 6H). 
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(E)-((E)-8-(tert-Butyldiphenylsilyloxy)-12-(4-methoxybenzyloxy)-2,10-dimethyl-
6-methylenedodec-10-en-4-yl) but-2-enoate (21): 
 
 To a solution of zinc dust (0.086 g, 1.31 mmol, 9.0 equiv) in THF (1.5 mL) 
was added lead (II) chloride (4.06 mg, 0.015 mmol, 0.10 equiv) upon brief exposure 
to air, followed by dibromomethane (0.051 mL, 0.730 mmol, 5.0 equiv) dropwise via 
syringe.  After being allowed the stir for 30 mins, the reaction was then cooled (0 °C) 
and a 1.0 M solution of titanium (IV) chloride (0.22 mL, 0.22 mmol, 1.5 equiv) in 
THF was added dropwise via a glass-syringe.  Then the reaction was allowed to 
warm to room temperature and stir for 30 mins at which time a solution of 20 (0.100 
g, 0.146 mmol, 1.0 equiv) in THF was added via cannula.  The reaction was allowed 
to stir overnight, and then was diluted with Et2O and DI H2O and transferred to a 
separatory funnel containing saturated NH4Cl (3 mL).  The aqueous phase was 
extracted with Et2O (2×5 mL), and the combined organics were washed with DI H2O 
(1×5 mL), dried over MgSO4, filtered through Celite and then concentrated under 
reduced pressured.  Purification by flash column chromatography (10:1 hexanes/ethyl 
acetate) gave 21 (0.048 g, 0.070 mmol, 48%). 
  Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3): δ 7.68 – 7.62 (m, 4H), 7.44 – 7.30 (m, 6H), 
7.23 – 7.18 (m, 3H), 6.94 – 6.80 (m, 3H), 5.78 – 5.68 (m, 1H), 5.32 (t, J = 6.1, 1H), 
5.01 – 4.91 (m, 1H), 4.74 (d, J = 5.3, 3H), 4.35 (s, 2H), 3.99 – 3.90 (m, 1H), 3.88 (d, 
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J = 6.7, 2H), 3.78 (s, 3H), 2.20 – 1.99 (m, 5H), 1.96 – 1.86 (m, 1H), 1.83 (dd, J = 6.9, 
1.7, 3H), 1.54 – 1.45 (m, 1H), 1.45 – 1.32 (m, 1H), 1.29 (s, 3H), 1.22 – 1.12 (m, 1H), 
0.99 (s, 9H), 0.82 (dd, 6H). 
(E)-((E)-8-(tert-Butyldiphenylsilyloxy)-12-hydroxy-2,10-dimethyl-6-oxododec-10-
en-4-yl) but-2-enoate (21A): 
 
 To a cooled (0 °C) solution of 21 (0.530 g, 0.78 mmol, 1.0 equiv) in 19:1 
CH2Cl2/DI H20 (18.4 mL/0.97 mL) was added DDQ (0.352 g, 1.55 mmol, 2.0 equiv) 
upon brief exposure to air.  After being allowed to stir for 1.5 h at 0 °C, the reaction 
was quenched with the addition of saturated NaHCO3 (10 mL) and then transferred to 
a separatory funnel.  The aqueous phase was extracted with CH2Cl2 (3×7 mL) and 
then the combined organics were dried over MgSO4, filtered through Celite and 
concentrated under reduced pressure.  Purification by flash column chromatography 
(7:1 hexanes/ethyl acetate) provided the free alcohol 21A (0.348 g, 0.618 mmol, 
80%). 
 Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3) δ 7.69 – 7.61 (m, 4H), 7.44 – 7.28 (m, 6H), 
6.88 (dq, J = 13.8, 6.9, 1H), 5.74 (dd, J = 15.5, 1.7, 1H), 5.28 (t, J = 6.4, 1H), 4.98 – 
4.89 (m, 1H), 4.76 (d, J = 4.6, 2H), 4.07 – 3.86 (m, 3H), 2.26 (dd, J = 14.2, 4.9, 1H), 
2.16 – 2.00 (m, J = 29.1, 14.0, 7.1, 4H), 1.92 (dd, J = 13.8, 7.0, 1H), 1.83 (dt, J = 5.0, 
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2.5, 3H), 1.57 – 1.47 (m, 1H), 1.47 – 1.35 (m, 1H), 1.30 (s, 3H), 1.27 – 1.19 (m, 1H), 
0.98 (s, J = 9.4, 9H), 0.82 (dd, J = 17.9, 6.6, 6H). 
(E)-((E)-8-(tert-Butyldiphenylsilyloxy)-2,10-dimethyl-6,12-dioxododec-10-en-4-
yl) but-2-enoate (22): 
 
 To a cooled (0 °C) solution of 21A (0.348 g, 0.62 mmol, 1.0 equiv) in CH2Cl2 
(6.2 mL) was added Dess-Martin periodinane
69
 (0.315 g, 0.74 mmol, 1.2 equiv) upon 
brief exposure to air.  After being allowed to stir for 2 h at 0 °C, the reaction was 
filtered through Celite and then quenched by the addition of saturated 1:1 
Na2S2O3/NaHCO3 (7 mL) and allowed to stir for another 2 h.  The crude mixture was 
then transferred to a separatory funnel and the aqueous phase was extracted with 
CH2Cl2 (3×5 mL).  The combined organics were dried over MgSO4, filtered through 
Celite and concentrated under reduced pressure.  Purification by flash column 
chromatography (10:1 hexanes/ethyl acetate) provided the desired aldehyde 22 (0.290 
g, 0.52 mmol, 84%) 
 Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3): δ 9.84 (d, J = 8.1, 1H), 7.68 – 7.60 (m, 4H), 
7.44 – 7.32 (m, 6H), 6.92 – 6.83 (m, 1H), 5.79 (d, J = 8.1, 1H), 5.72 (dd, J = 15.5, 
1.7, 1H), 4.98-4.89 (m, 1H), 4.74 (d, J = 26.0, 2H), 4.06 – 3.95 (m, 1H), 2.36 – 2.10 
(m, 4H), 2.00 (dd, J = 14.4, 7.3, 1H), 1.85 – 1.82 (m, 4H), 1.56 – 1.43 (m, 4H), 1.43 – 
1.33 (m, 1H), 1.20 – 1.09 (m, 1H), 0.99 (s, 9H), 0.82 (dd, J = 15.0, 6.6, 6H). 
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(3E,7E)-10-(tert-Butyldiphenylsilyloxy)-6-hydroxy-14-isobutyl-8-methyl-12-
methyleneoxacyclotetradeca-3,7-dien-2-one (23): 
 
 To a flask containing 2,6-diphenylphenol (0.290 g, 1.18 mmol, 6.6 equiv) was 
added toluene (2 mL) via cannula and then N2 was bubbled through the solution for 
15 mins.  Trimethylaluminum (0.20 mL, 2.0 M solution in hexanes, 0.39 mmol, 2.2 
equiv) was then added to the reaction solution dropwise via syringe.  The pale yellow 
solution was allowed to stir for 30 mins at room temperature and then it was cooled  
(-78 °C), at which point a solution of 22 (0.100 g, 0.178 mmol, 1.0 equiv) in toluene 
(1.8 mL) was added to the reaction via cannula.  This 22/ATPH solution was then 
allowed to stir at -78 °C for 45 min.  Meanwhile, to a separate cooled (-78 °C) 
solution of 2,2,6,6-tetramethylpiperidine (0.08 mL, 0.46 mmol, 2.6 equiv) in THF 
(1.2 mL) was added n-butyllithium (0.295 mL, 1.51 M solution in hexanes, 0.45 
mmol, 2.5 equiv) dropwise via syringe.  This LTMP solution was allowed to stir for 
30 mins at -78 °C (during which the solution changed from clear to cloudy pale 
yellow), at which point more toluene (9 mL) was added to the solution via cannula.  
Then the 22/ATPH solution was added to the LTMP solution slowly via cannula over 
45 mins.  The reaction was allowed to stir for 4.5 h and was then quenched by the 
addition of isopropanol (1 mL), and then saturated NH4Cl (10 mL) was added quickly 
thereafter.  The biphasic mixture was allowed to warm to room temperature, then 
filtered through Celite and transferred to a separatory funnel.  The aqueous phase was 
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extracted with Et2O (3×5 mL), and then the combined organics were washed with 
brine (1×5 mL), dried over MgSO4, filtered through Celite and concentrated under 
reduced pressure.  Purification by flash column chromatography (6:1 hexanes/ethyl 
acetate) provided a mixture of products which needed to be separated via HPLC.  
HPLC runs were executed with a micro-porasil column, injecting 100 μL of a  
1 mg/100 μL solution per run, flow rate of 1.5 mL/min and with 5:1 hexanes/ethyl 
acetate as the eluent. 
 One isolated product’s 1H NMR (500 MHz, CDCl3): δ 7.71 – 7.65 (m, 4H), 
7.46 – 7.33 (m, 6H), 6.48 (dt, J = 16.2, 8.2, 1H), 5.51 (d, J = 15.8, 1H), 5.01 – 4.83 
(m, J = 17.2, 2H), 4.73 (s, 3H), 4.61 (d, J = 9.7, 1H), 4.40 – 4.27 (m, J = 9.4, 1H), 
3.94 – 3.78 (m, 1H), 2.69 – 2.55 (m, 1H), 2.29 – 2.20 (m, 3H), 2.12 – 1.95 (m, 7H), 
1.56 (s, J = 1.2, 3H), 0.99 (s, 9H), 0.87 (dd, J = 6.6, 3.1, 6H). 
(S,E)-3-Hydroxy-7-(4-methoxybenzyloxy)-5-methyl-1-((R)-2-thioxo-4-(2-(tri-
ethylsilyloxy)propan-2-yl)thiazolidin-3-yl)hept-5-en-1-one (24): 
 
To a cooled (0 °C) solution of thiazolidinethione 9
8-10
 (0.840 g, 2.52 mmol, 
1.3 equiv) in CH2Cl2 (11 mL) was added dichlorophenyl borane (0.33 mL, 2.52 
mmol, 1.3 equiv) dropwise via syringe.  The resulting yellow-orange solution was 
allowed to stir at 0 °C for 10 min, then (‒)-sparteine (1.2 mL, 5.04 mmol, 2.6 equiv) 
was slowly added via syringe.  The reaction was allowed to warm to room 
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temperature and stir for a total of 45 min, at which time the solution was then cooled 
to -78 °C and aldehyde 16 (0.455 g, 1.94 mmol, 1.0 equiv) was added.  After stirring 
for 2 h at -78 °C, the solution was allowed to warm to 0 °C slowly over 18 h.  The 
reaction was then diluted with an equal volume of hexanes and quenched at 0 °C with 
30% H2O2 (6 mL).  Vigorous stirring at 0 °C was continued for 20 min. The solution 
was diluted further with 4:1 hexanes/CH2Cl2, and then transferred to a separatory 
funnel.  The organic phase was extracted with DI H2O (1×5 mL) and brine (1×5 mL), 
dried over MgSO4, filtered through Celite, and concentrated under reduced pressure 
to give 24 as a bright-yellow oil.  Due to decomposition during flash column 
chromatography, the crude material was used directly in the next reaction.  However, 
a portion of this material was purified by flash column chromatography (4:1 
hexanes:ethyl acetate) using neutral silica gel. 
1H NMR (500 MHz): δ 7.26 – 7.22 (m, 2H), 6.88 – 6.84 (m, 2H), 5.50 – 5.44 
(m, 1H), 5.30 (dd, J = 1.0, 8.1, 1H), 4.42 (s, 2H), 4.22 – 4.16 (m, 1H), 3.98 (d, J = 
6.6, 2H), 3.78 (s, 3H), 3.48 (dd, , J = 9.3, 17.6, 1H), 3.45 (dd, 1H, J = 8.1, 11.4 Hz), 
3.38 (dd, 1H, J=1.0, 11.5 Hz), 3.29 (dd, J = 2.9, 17.3, 1H), 3.14 (d, J = 4.3, 1H), 2.26 
(dd, J = 7.5, 13.6, 2H), 1.66 (s, 3H), 1.28 (s, 3H), 1.24 (s, 3H), 0.96 – 0.90 (m, 9H), 
0.62 – 0.56 (m, 6H). 
(S,E)-3-Hydroxy-N-methoxy-7-(4-methoxybenzyloxy)-N,5-dimethylhept-5-
enamide (25): 
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To a solution of crude 24 (1.10 g, 1.94 mmol, 1.0 equiv) in 1:1 toluene/ 
CH2Cl2 (9.7 mL/9.7 mL) was added imidazole (0.791 g, 11.6 mmol, 6.0 equiv), 
triethylamine (0.82 mL, 5.81 mmol, 3.0 equiv), and N,O-dimethyl hydroxylamine 
(0.567 g, 5.81 mmol, 3.0 equiv).  The reaction was allowed to stir at room 
temperature for 4 h.  The reaction was then diluted with CH2Cl2 and quenched with 
saturated NaHCO3, and transferred to a separatory funnel.  The aqueous phase was 
extracted with CH2Cl2 (3×10 mL), and the combined organic phases were dried over 
MgSO4, filtered through Celite, and concentrated under reduced pressure.  
Purification by flash column chromatography (2:3 hexanes/ethyl acetate) gave 25 
(0.516 g, 1.53 mmol, 79% over two steps) as a yellow oil. 
IR (cm
-1
): 3442, 2934, 2855, 1648, 1613, 1514.  
1H NMR (500 MHz): δ 7.28 
– 7.24 (m, J = 4.2, 2H), 6.91 – 6.84 (m, 2H), 5.50 (t, J = 6.2, 1H), 4.44 (s, 2H), 4.28 – 
4.18 (m, 1H), 4.07 – 3.97 (m, 2H), 3.81 (s, 3H), 3.67 (s, 3H), 3.64 (br d, J = 1.7, 1H), 
3.20 (s, 3H), 2.67 (d, J = 16.5, 1H), 2.48 (dd, J = 16.7, 9.3, 1H), 2.33 (dd, J = 13.6, 
7.6, 1H), 2.21 (dd, J = 13.6, 5.9, 1H), 1.71 (s, 3H).  
13
C NMR (100 MHz, CDCl3): δ 
173.53, 159.08, 136.66, 130.44, 129.37, 124.24, 113.68, 77.32, 77.00, 76.68, 71.74, 
66.08, 65.99, 61.20, 55.22, 46.68, 37.74, 31.80, 16.66. [α]27D = +16.0 (c 1.13, 
CH2Cl2). 
(S,E)-N-Methoxy-7-(4-methoxybenzyloxy)-N,5-dimethyl-3-(triisopropylsilyloxy) 
hept-5-enamide (26): 
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 To a solution of 25 (0.050 g, 0.17 mmol, 1.0 equiv) in DMF (0.9 mL) was 
added imidazole (0.023 g, 0.34 mmol, 2.0 equiv) upon brief exposure to air.  Then 
TBDPS-Cl (0.06 mL, 0.22 mmol, 1.3 equiv) was added dropwise via syringe, upon 
which a white precipitate formed.  The reaction was allowed to stir overnight and was 
then quenched by the addition of saturated NaHCO3 (3 mL).  The crude mixture was 
transferred to a separatory funnel and the aqueous phase was extracted with CH2Cl2 
(3×3 mL).  The combined organics were dried over MgSO4, filtered through Celite 
and then concentrated under reduced pressure.  Purification by flash column 
chromatography (6:1 hexanes/ethyl acetate) gave the protected product 26 (0.089 g, 
0.168 mmol, 98%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.71 – 7.65 (m, 6H), 7.43 – 7.29 (m, 4H), 7.23 
– 7.16 (m, 2H), 6.87 – 6.79 (m, 2H), 5.30 (t, J = 6.1, 1H), 4.47 – 4.37 (m, 1H), 4.33 
(s, 3H), 3.84 (d, J = 6.6, 2H), 3.77 (s, 3H), 3.58 (s, 3H), 3.09 (s, 3H), 2.74 – 2.62 (m, 
1H), 2.42 (dd, J = 15.2, 4.9, 1H), 2.16 (d, J = 6.6, 2H), 1.20 (s, 3H), 0.99 (d, J = 6.3, 
9H). 
(S,E)-4-(tert-Butyldiphenylsilyloxy)-8-(4-methoxybenzyloxy)-6-methyloct-6-en-2-
one (27): 
 
 To a cooled (0 °C) solution of 26 (0.168 g, 0.29 mol, 1.0 equiv) in Et2O (2.9 
mL) was added methyllithium (0.37 mL, 1.6 M solution in Et2O, 0.58 mmol, 2.0 
equiv) dropwise via syringe.  The reaction was allowed to stir for 45 mins at 0 °C and 
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was then quenched by the addition of saturated NH4Cl (4 mL) and allowed to warm 
to room temperature.  The crude mixture was transferred to a separatory funnel and 
the aqueous phase was extracted with CH2Cl2 (3×3 mL).  The combined organics 
were dried over MgSO4, filtered through Celite and concentrated under reduced 
pressure.  Purification by flash column chromatography (6:1 hexanes/ethyl acetate) 
gave the desired ketone 27 (0.135 g, 0.25 mmol, 87%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.70 – 7.61 (m, J = 6.8, 0.9, 4H), 7.45 – 7.31 
(m, 6H), 7.23 – 7.17 (m, 2H), 6.88 – 6.80 (m, 2H), 5.28 (t, J = 6.6, 1H), 4.34 (s, 2H), 
4.34 – 4.28 (m, 1H), 3.85 (d, J = 6.6, 2H), 3.78 (s, 3H), 2.59 – 2.42 (m, 2H), 2.20 – 
2.05 (m, 2H), 2.01 (s, 3H), 1.25 (s, 3H), 1.00 (s, 9H). 
(S,E)-6-(4-(4-Methoxybenzyloxy)-2-methylbut-2-enyl)-2,2,9,9-tetramethyl-4-
methylene-8,8-diphenyl-3,7-dioxa-2,8-disiladecane (28): 
 
To a cooled (0 °C) solution of diisopropylamine (0.04 mL, 0.258 mmol, 1.6 
equiv) in THF (0.8 mL) was added n-butyllithium (0.16 mL, 1.47 M solution in 
hexanes, 0.242 mmol, 1.5 equiv) dropwise via syringe.  The solution of LDA was 
allowed to stir at 0 °C for 30 mins and was then cooled (-78 °C), at which time a 
solution of 27 (0.086 g, 0.161 mmol, 1.0 equiv) and chlorotrimethylsilane (0.03 mL, 
0.242 mmol, 1.5 equiv) in THF (0.5 mL) was added via cannula.  The reaction was 
allowed to stir at -78 °C for 45 mins, then allowed to warm to 0 °C and was then 
quenched by the addition of saturated NaHCO3 (3 mL).  The crude mixture was 
119 
 
transferred to a separatory funnel and the organic phase was washed with NaHCO3 
(3×3 mL), and then the combined aqueous was extracted with hexanes (3×3 mL).  
The combined organics were dried over MgSO4, filtered through Celite and then 
concentrated under reduced pressure to give the enol ether 28 (0.087 g, 0.144 mmol, 
90%).  Upon purification, the enol ether was found to revert back to starting material 
and therefore, flash column chromatography was avoided. 
1
H NMR (500 MHz, CDCl3): δ 7.69 – 7.62 (m, 4H), 7.42 – 7.29 (m, 6H), 7.23 
– 7.20 (m, 2H), 6.87 – 6.80 (m, 2H), 5.34 (t, J = 6.2, 1H), 4.36 (s, 2H), 4.10 – 4.02 
(m, 1H), 3.96 (d, J = 1.5, 2H), 3.88 (qd, J = 11.9, 6.7, 2H), 3.78 (s, 3H), 2.25 – 2.04 
(m, 4H), 1.26 (s, 3H), 1.00 (s, 9H), 0.09 – 0.05 (m, 9H). 
General 1,5-Anti Aldol Reaction Procedure: 
 
 To a cooled (-78 °C) solution of the ketone (0.160 mmol, 1.0 equiv) and the 
amine base (0.045 mL, 0.256 mmol, 1.6 equiv) in Et2O (1.6 mL) was added the boron 
Lewis acid (0.24 mL, 1.0 M solution in toluene, 0.24 mmol, 1.5 equiv) dropwise via 
syringe.  The reaction was allowed to stir for 30 mins and then a solution of the 
aldehyde (0.24 mL, 1.0 M in THF, 0.24 mmol, 1.5 equiv) in THF was added slowly 
via syringe pump over 1 h.  After being allowed to stir for 2 h at -78 °C, the reaction 
was allowed to warm to 0 °C and then 1.2 mL of a 1:6 pH=7 buffer/MeOH solution 
was added via syringe.  Next, 0.5 mL of a 1:2 30% H2O2/MeOH solution was added 
to the reaction via syringe.  Finally, the reaction was then allowed to warm to room 
temperature and stir for 1 h, at which point it was transferred to a separatory funnel.  
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The aqueous phase was extracted with Et2O (2×5 mL) and then the combined 
organics were washed with saturated NaHCO3 (1×5 mL) and brine (1×5 mL).  The 
organics were then dried over MgSO4, filtered through Celite and then concentrated 
under reduced pressure.  Purification by flash column chromatography gave the 
desired aldol product. 
(E)-9-Hydroxy-5-(4-(4-methoxybenzyloxy)-2-methylbut-2-enyl)-2,2,13,13,14,14-
hexamethyl-3,3-diphenyl-4,12-dioxa-3,13-disilapentadecan-7-one: 
 
 Purification by flash column chromatography using 1:1 hexanes/ethyl acetate 
gave a mixture of aldol product diastereomers. 
Unless otherwise indicated, 
1
H NMR signals correspond to both diastereomers 
of the product.  
1
H NMR (500 MHz, CDCl3) δ 7.69 – 7.61 (m, 4H), 7.43 – 7.32 (m, 
6H), 7.22 – 7.16 (m, 2H), 6.87 – 6.80 (m, 2H), 5.28 (t, J = 6.6, 1H), 4.38 – 4.27 (m, 
3H), 4.18 – 4.08 (m, 1H), 3.84 (d, J = 6.6, 2H), 3.82 – 3.69 (m, 5H), 3.47 (d, J = 2.6, 
1H), 2.61 – 2.37 (m, 4H), 2.22 – 2.02 (m, 2H), 1.65 – 1.47 (m, 2H), 1.22 (s, 3H), 0.99 
(s, 9H), 0.91 – 0.83 (m, 9H), 0.09 – -0.01 (m, J = 1.3, 6H). 
(E)-7-Hydroxy-11-(4-(4-methoxybenzyloxy)-2-methylbut-2-enyl)-14,14-dimethyl-
13,13-diphenyl-2,4,12-trioxa-13-silapentadecan-9-one: 
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 Purification by flash column chromatography using 2:1 hexanes/ethyl acetate 
gave a mixture of aldol product diastereomers. 
Unless otherwise indicated, 
1
H NMR signals correspond to both diastereomers 
of the product.  
1
H NMR (500 MHz, CDCl3) δ 7.70 – 7.61 (m, 4H), 7.44 – 7.32 (m, 
6H), 7.23 – 7.17 (m, 2H), 6.87 – 6.79 (m, 2H), 5.28 (t, J = 6.5, 1H), 4.58 (s, 0.6H, 
minor diastereomer), 4.58 (s, 1.4H, major diastereomer), 4.38 – 4.26 (m, 3H), 4.17 – 
4.05 (m, 1H), 3.84 (d, J = 6.6, 2H), 3.77 (s, 3H), 3.68 – 3.54 (m, 2H), 3.33 (s, 3H), 
3.21 (d, J = 3.3, 0.3H, minor diastereomer), 3.17 (d, J = 3.1, 0.7H, major 
diasteromer), 2.57 – 2.35 (m, 4H), 2.21 – 2.06 (m, 2H), 1.70 – 1.55 (m, 2H), 1.23 (s, 
3H), 1.02 – 0.96 (m, 9H). 
(E)-8-(4-Methoxybenzyloxy)-4-(methoxymethoxy)-6-methyloct-6-en-2-one (31): 
 
 To a cooled (0 °C) solution of alcohol (0.41 g, 1.41 mmol, 1.0 equiv) in 
CH2Cl2 (2.8 mL) was added diisopropylethylamine (0.61 mL, 3.53 mmol, 2.5 equiv) 
and chloromethyl methyl ether (0.21 mL, 2.82 mmol, 2.0 equiv) both dropwise via 
syringe.  The reaction was allowed to warm to room temperature and stir overnight, at 
which time the dark orange solution was then diluted with CH2Cl2 (3 mL) and 
transferred to a separatory funnel.  The organic phase was washed with 5% aqueous 
HCl (3×5 mL), and then the combined organics were dried over MgSO4, filtered 
through Celite and concentrated under reduced pressure.  Purification by flash column 
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chromatography (2:1 hexanes/ethyl acetate) gave the desired protected alcohol 31 
(0.41 g, 1.21 mmol, 86%). 
 
1
H NMR (500 MHz, CDCl3): δ7.28 – 7.17 (m, 2H), 6.91 – 6.81 (m, 2H), 5.42 
(t, J = 7.5, 1H), 4.61 (q, J = 6.9, 2H), 4.40 (s, 2H), 4.24 – 4.16 (m, 1H), 3.96 (d, J = 
6.6, 2H), 3.78 (s, 3H), 3.30 (s, 3H), 2.65 (dd, J = 16.5, 7.8, 1H), 2.50 (dd, J = 16.5, 
4.4, 1H), 2.37 (dd, J = 13.4, 5.9, 1H), 2.23 – 2.07 (m, 4H), 1.65 (s, 3H). 
Triisopropyl(pent-4-yn-2-yloxy)silane (36): 
 
 To a solution of 4-pentyn-2-ol (1.0 mL, 10.6 mmol, 1.0 equiv) in CH2Cl2 
(13.3 mL) was added triisopropylchlorosilane (2.9 mL, 13.8 mmol, 1.3 equiv) 
dropwise via syringe.  Imidazole (1.08 g, 15.9 mmol, 1.5 equiv) was then added upon 
brief exposure to air, upon which a white precipitate formed.  The reaction was 
allowed to stir overnight, at which time it was quenched by the addition of saturated 
NaHCO3 (10 mL).  The crude mixture was then transferred to a separatory funnel, 
and the aqueous phase was extracted with CH2Cl2 (3×5 mL), and then combined 
organics were dried over MgSO4, filtered through Celite and concentrated under 
reduced pressure.  Purification by flash column chromatography (hexanes) provided 
the alkyne 36 (2.08 g, 8.63 mmol, 81%) as a clear oil. 
 
1
H NMR (500 MHz, CDCl3): δ 4.12 – 3.98 (m, 1H), 2.47 – 2.35 (m, 1H), 2.25 
(ddd, J = 16.5, 8.1, 2.7, 1H), 1.96 (t, J = 2.7, 1H), 1.28 (d, J = 6.0, 3H), 1.12 – 0.97 
(m, 21H). 
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Triisopropyl(4-(tributylstannyl)pent-4-en-2-yloxy)silane (38): 
 
 To a cooled (0 °C) solution of diisopropylamine (0.74 mL, 5.20 mmol, 2.5 
equiv) in THF (21 mL) was added n-butyllithium (3.4 mL, 1.52 M solution in 
hexanes, 5.20 mmol, 2.5 equiv) dropwise via syringe.  The solution of LDA was 
allowed to stir at 0 °C for 20 mins, and then tributyltin hydride (1.3 mL, 4.78 mmol, 
2.3 equiv) was added dropwise via syringe.  The pale yellow solution was allowed to 
stir for 1 h, at which point it was then cooled (-40 °C) via an acetonitrile/dry ice bath.  
The dark orange/brown solution was allowed to stir at -40 °C for 30 mins at which 
point it was cooled (-78 °C) and then methanol (0.14 mL, 3.33 mmol, 1.6 equiv) was 
added via syringe, followed by a solution of 36 (0.500 g, 2.1 mmol, 1.0 equiv) in THF 
(2 mL) was added to the reaction via cannula.  The solution was allowed to stir for  
2 h, and then methanol (3.9 mL, 96.0 mmol, 46 equiv) was added via syringe, and the 
reaction was allowed to warm to 0 °C and stir for another 30 mins.  The reaction was 
then quenched by the addition of 9:1 saturated NH4Cl/NH4OH (10 mL), and the black 
crude mixture was transferred to a separatory funnel.  The aqueous phase was 
extracted with Et2O (3×10 mL), and then the combined organics were dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure to give the 
vinyl tin species 38.  Purification by flash column chromatography was found to 
reduce the tin to give the undesired terminal alkene, and therefore the crude material 
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(1.81 g, 164% - excess yield due to by-products) was used directly in the next 
reaction. 
(4-Bromopent-4-en-2-yloxy)triisopropylsilane (37): 
 
 To a cooled (0 °C) solution of crude 38 (1.81 g, 3.41 mmol, 1.0 equiv – note: 
a portion of this crude material was by-products from the previous reaction) in 
CH2Cl2 (34 mL) was added N-bromosuccinimide (0.758 g, 4.26 mmol, 1.25 equiv) in 
one portion upon brief exposure to air.  The orange solution was allowed to stir for 1 
h at 0 °C, at which point the reaction was quenched by the addition of saturated 
Na2SO3 (10 mL) and allowed to warm to room temperature.  The crude solution was 
then transferred to a separatory funnel, and the organic phase was washed with 
Na2SO3 (2×7 mL), and 1M NaOH (3×7 mL).  The combined aqueous phases were 
then extracted with Et2O (3×7 mL), and then the combined organics were dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  Purification 
by flash column chromatography (hexanes) provided the desired vinyl bromide 37 
(0.53 g, 1.64 mmol, 79% - based on theoretical yield of the previous reaction). 
1
H NMR (500 MHz, CDCl3): δ 5.60 (s, 1H), 5.41 (s, 1H), 4.27 – 4.17 (m, 1H), 
2.68 (dd, J = 14.0, 5.4, 1H), 2.42 (dd, J = 13.9, 7.4, 1H), 1.18 (d, J = 6.0, 4H), 1.07 – 
1.04 (m, 21H). 
(4-Iodopent-4-en-2-yloxy)triisopropylsilane (39): 
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 Vinyl iodide 39 was prepared in the same method as vinyl bromide 37, except 
that N-iodosuccinimide (1.5 equiv) was used and the reaction was allowed to take 
place at -78 °C (warmer temperatures produced the trans-substituted alkenyliodide).  
Vinyl tributyltin 38 (1.85 g, 3.48 mmol – note: a significant portion of crude material 
was by-products from the previous reaction, at most only 0.360 g, 0.678 mmol, of this 
material is 38) gave the vinyl iodide (0.212 g, 0.576 mmol, 85% - based on 
theoretical yield of the previous reaction). 
 
1
H NMR (500 MHz, CDCl3): δ 6.06 (s, 1H), 5.74 (s, 1H), 4.24 – 4.09 (m, 1H), 
2.67 (dd, J = 13.8, 5.1, 1H), 2.36 (ddd, J = 13.9, 7.5 1H), 1.16 (d, J = 6.0, 3H), 1.07 – 
1.05 (m, 21H). 
((But-3-enyloxy)methyl)benzene (40)
70
: 
 
 To a cooled (0 °C) solution of washed sodium hydride (hexanes, 3×10 mL) 
(1.85 g, 60% in mineral oil, 46.3 mmol, 1.7 equiv) in THF (62 mL) was added 3-
buten-1-ol (2.4 mL, 27.7 mmol, 1.0 equiv) dropwise via syringe.  The reaction was 
allowed to warm to room temperature and stir for 1 h, and then benzyl bromide (4.0 
mL, 33.3 mmol, 1.2 equiv) was added dropwise via syringe.  The mixture was 
allowed to stir overnight, at which time it was then quenched by the addition of brine 
(30 mL).  The crude mixture was transferred to a separatory funnel and the aqueous 
phase was extracted with Et2O (3×10 mL), and then the combined organics were 
dried over MgSO4, filtered through Celite and concentrated under reduced pressure.  
Distillation under high vac (bp ~95 °C) provided the known benzyl alcohol 40 (4.25 
g, 26.2 mmol, 94%) as a clear oil. 
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1
H NMR (500 MHz, CDCl3): δ 7.43 – 7.20 (m, 5H), 5.91 – 5.74 (m, 1H), 5.16 
– 4.95 (m, 2H), 4.51 (s, 2H), 3.51 (t, J = 6.8, 2H), 2.49 – 2.22 (m, 2H). 
2-(2-(benzyloxy)ethyl)oxirane (41)
70
: 
 
 To a cooled (0 °C) solution of 41 (4.50 g, 27.7 mmol, 1.0 equiv) in CH2Cl2 
(92 mL) was added mCPBA (9.57 g, 55.5 mmol, 2.0 equiv) upon brief exposure to 
air.  The reaction was allowed to warm to room temperature and then stir overnight, 
at which time it was quenched by the addition of saturated NaHCO3 (50 mL).  The 
crude mixture was transferred to a separatory funnel and the organic phase was 
washed with saturated NaHCO3 (2×10 mL) and then the combined aqueous phases 
were extracted with CH2Cl2 (1×10 mL).  The combined organics were dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  Flash 
column chromatography (5:1 hexanes/ethyl acetate provided the known epoxide 41 
(3.59 g, 20.14 mmol, 73%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.37 – 7.21 (m, 5H), 4.52 (s, 2H), 3.69 – 3.52 
(m, 2H), 3.13 – 2.99 (m, 1H), 2.82 – 2.72 (m, 1H), 2.51 (dd, J = 5.0, 2.7, 1H), 1.90 
(dddd, J = 14.3, 7.2, 6.2, 4.7, 1H), 1.76 (ddd, J = 14.4, 12.0, 6.0, 1H). 
4-(Benzyloxy)-1-bromobutan-2-ol (52): 
 
 To a solution of 41 (0.100 mg, 0.56 mmol, 1.0 equiv) in Et2O (5.6 mL), was 
added magnesium bromide ethyl etherate (0.362 g, 1.40 mmol, 2.5 equiv) upon brief 
exposure to air.  After 10 mins the reaction was quenched by the addition of saturated 
127 
 
NaHCO3 (5 mL), upon which a white precipitate formed.  The crude mixture was 
transferred to a separatory funnel and then the aqueous phase was extracted with ethyl 
acetate (3×3 mL).  The combined organics were washed with DI H2O (1×3 mL), 
dried over MgSO4, filtered through Celite and concentrated under reduced pressure.  
Purification by flash column chromatography (5:1 hexanes/ethyl acetate) gave the 
desired bromo-halohydrin 52 (0.125 g, 0.48 mmol, 86%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.37 – 7.25 (m, 5H), 4.51 (s, 2H), 4.06 – 3.96 
(m, 4.1, 1H), 3.67 (dddd, J = 33.2, 9.4, 6.8, 4.6, 2H), 3.43 (ddd, J = 16.5, 10.3, 5.5, 
2H), 3.10 (d, J = 4.0, 1H), 1.97 – 1.78 (m, 2H). 
4-(Benzyloxy)-1-iodobutan-2-ol (52A): 
 
 To a suspension of magnesium (0.341 g, 14.0 mmol, 5.0 equiv) in Et2O (14 
mL) was added iodine (1.78 g, 7.01 mmol, 2.5 equiv) upon brief exposure to air.  The 
flask was then placed in a sonicator until the suspension decolored.  Then a solution 
of epoxide 41 (0.500 g, 2.81 mmol, 1.0 equiv) in Et2O (14 mL) was added to the 
reaction suspension via cannula.  After 5 mins the reaction was quenched by the 
addition of saturated NaHCO3 (20 mL), upon which a white precipitate formed.  The 
crude mixture was transferred to a separatory funnel (leaving remaining magnesium 
behind), and the aqueous phase was extracted with ethyl acetate (3×10 mL).  The 
combined organics were washed with DI H2O (1×10 mL), dried over MgSO4, filtered 
through Celite and concentrated under reduced pressure.  Purification by flash column 
chromatography (5:1 hexanes/ethyl acetate) provided the iodo-halohydrin 52A (0.739 
g, 2.41 mmol, 86%). 
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1
H NMR (500 MHz, CDCl3): δ 7.39 – 7.26 (m, 5H), 4.50 (s, 2H), 3.86 – 3.74 
(m, 1H), 3.67 (dddd, J = 11.8, 9.5, 6.9, 4.4, 2H), 3.26 (ddd, J = 16.2, 10.1, 5.5, 2H), 
3.14 (d, J = 3.9, 1H), 2.00 – 1.77 (m, 2H). 
(E)-4-(Benzyloxy)-1-bromobutan-2-yl but-2-enoate (53): 
 
 To a cooled (0 °C) solution of 52 (0.040 g, 0.15 mmol, 1.0 equiv) in CH2Cl2 
(1.5 mL) was added crotonic anhydride (0.045 mL, 0.305 mmol, 2.0 equiv) dropwise 
via syringe.  DMAP (0.047 g, 0.038 mmol, 2.5 equiv) was then added upon brief 
exposure to air.  The reaction was then allowed to stir at 0 °C overnight, at which 
time it was quenched by the addition of saturated NaHCO3 and transferred to a 
separatory funnel.  The aqueous phase was extracted with CH2Cl2 (3×3 mL), and then 
the combined organics were dried over MgSO4, filtered through Celite and 
concentrated under reduced pressure.  Purification by flash column chromatography 
(15:1 hexanes/ethyl acetate) provided the alkyl bromide 53 (0.038 g, 0.12 mmol, 
76%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.35 – 7.25 (m, 5H), 6.99 (dq, J = 15.5, 6.9, 
1H), 5.82 (dq, J = 15.5, 1.7, 1H), 4.97 – 4.82 (m, 1H), 4.46 (s, 2H), 3.54 – 3.47 (m, 
2H), 3.45 (dd, J = 10.7, 4.8, 1H), 3.31 (dd, J = 10.7, 4.9, 1H), 2.01 – 1.94 (m, 6.1, 
2H), 1.87 (dd, J = 6.9, 1.7, 3H). 
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(E)-4-(benzyloxy)-1-iodobutan-2-yl but-2-enoate (53): 
 
 Alkyl iodide 54 was prepared in the same method as alkyl bromide 53.  Iodo-
halohydrin 52A (0.148 g, 0.48 mmol) gave the alkyl iodide (0.125 g, 0.33 mmol, 
69%). 
 
1
H NMR (500 MHz, CDCl3): δ 7.35 – 7.25 (m, 5H), 6.99 (dq, J = 15.5, 6.9, 
1H), 5.83 (dq, J = 15.5, 1.7, 1H), 5.26 – 5.18 (m, 1H), 4.46 (s, 2H), 3.61 (dd, J = 11.0, 
4.4, 1H), 3.57 – 3.39 (m, 3H), 2.08 – 1.93 (m, 2H), 1.87 (dd, J = 6.9, 1.7, 3H). 
Diisopropyl(pent-4-yn-2-yloxy)silane (57): 
 
 To a cooled (0 °C) solution of 4-pentyn-2-ol (0.56 mL, 5.94 mmol, 1.0 equiv) 
in CH2Cl2 (30 mL) was added DMAP (0.073 g, 0.59 mmol, 0.10 mmol) upon brief 
exposure to air.  To the reaction was then added triethylamine (0.84 mL, 6.00 mmol, 
1.01 equiv) followed by chlorodiisopropylsilane (1.03 mL, 6.00 mmol, 1.01 equiv) 
both dropwise via syringe.  The reaction was allowed to stir for 30 mins at 0 °C and 
then transferred to a separatory funnel.  The organic phase was then washed with 1 M 
HCl (1×30 mL), saturated NaHCO3 (1×30 mL) and brine (1×30 mL), dried over 
MgSO4, filtered through Celite and concentrated under reduced pressure.  The crude 
material was used directly in the following reaction. 
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1
H NMR (500 MHz, CDCl3): δ 4.16 (t, J = 1.6, 1H), 4.03 – 3.88 (m, 1H), 2.40 
(ddd, J = 16.5, 5.2, 2.7, 1H), 2.27 (ddd, J = 16.5, 7.2, 2.7, 1H), 1.97 (t, J = 2.7, 1H), 
1.27 (d, J = 6.1, 3H), 1.08 – 0.97 (m, 14H). 
 
2,2-Diisopropyl-5-methyl-3-methylene-1,2-oxasilolane (58): 
 
 To a crude solution of 57 (1.18 g, 5.94 mmol, 1.0 equiv) in CH2Cl2 (30 mL) 
was added a solution of chloroplatinic acid hexahydrate (0.031 g, 0.059 mmol, 0.01 
equiv) in isopropanol (0.1 mL) via cannula.  The yellow/orange solution was then 
allowed to stir for 10 mins, at which point the solution had become dark red.  The 
crude mixture was concentrated under reduced pressure.  Purification by flash column 
chromatography (35:1 hexanes/ethyl acetate) gave the siloxane 58 (0.377 g, 1.90 
mmol, 32%).  It was found that 58 converted to vinyl silanol 59 during purification, 
and therefore, flash column chromatography should be avoided. 
 
1
H NMR (500 MHz, CDCl3): δ 5.76 (td, J = 2.8, 1.5, 1H), 5.36 (td, J = 2.9, 
1.8, 1H), 4.16 – 4.03 (m, 1H), 2.57 (ddt, J = 15.3, 5.1, 1.6, 1H), 2.12 (ddt, J = 15.2, 
9.0, 2.9, 1H), 1.25 (d, J = 6.0, 3H), 1.08 – 0.93 (m, 14H). 
(4-hydroxypent-1-en-2-yl)diisopropylsilanol (59): 
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 To a solution of 58 (0.02 g, 0.101 mmol, 1.0 equiv) in 1:1 acetonitrile/DI H2O 
(0.5 mL/0.5 mL) was added pyridinium p-toluene sulfonate (5 mg, 0.020 mmol, 0.20 
equiv) upon brief exposure to air.  The reaction was allowed to stir overnight, and 
was then transferred to a separatory funnel.  The organic phase was washed with 
saturated NaHCO3 (2×3 mL) and the combined aqueous phases were extracted with 
ethyl acetate (3×3 mL).  The combined organics were dried over MgSO4, filtered 
through Celite and concentrated under reduced pressure.  Purification by flash column 
chromatography (5:1 hexanes/ethyl acetate) gave the vinyl silanol 59. 
1
H NMR (500 MHz, CDCl3): δ 5.75 – 5.67 (m, 1H), 5.45 – 5.39 (m, 1H), 3.94 
– 3.85 (m, 1H), 2.39 (dd, J = 13.6, 2.9, 1H), 2.26 (dd, J = 13.7, 8.1, 1H), 1.18 (d, J = 
6.2, 3H), 1.05 – 0.92 (m, 14H). 
(But-3-enyloxy)(tert-butyl)dimethylsilane (62): 
 
 To a solution of 3-buten-1-ol (0.30 mL, 3.47 mmol, 1.0 equiv) in CH2Cl2 (4.3 
mL) was added tert-butyldimethylsilylchloride (0.523 g, 3.47 mmol, 1.0 equiv) and 
imidazole (0.354 g, 5.20 mmol, 1.5 equiv) both upon brief exposure to air, at which 
point a white, chunky precipitate formed.  The reaction was allowed to stir overnight, 
and was then quenched by the addition of saturated NaHCO3, transferred to a 
separatory funnel and the aqueous phase was extracted with CH2Cl2 (3×5 mL).  
Combined organics were dried over MgSO4, filtered and concentrated under reduced 
pressure.  A white precipitate remained, and was removed from the desired oil by 
filtering through Celite and rinsing with hexanes to give the protected alcohol 62 
(0.339 g, 1.82 mmol, 52%). 
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 IR (cm
-1
): 2923, 2852.  
1
H NMR (500 MHz, CDCl3): δ 5.85 – 5.74 (m, J = 
17.1, 10.2, 6.9, 1H), 5.09 – 4.96 (m, 2H), 3.64 (t, J = 6.8, 2H), 2.25 (qt, J = 6.8, 1.3, 
2H), 0.87 (s, 9H), 0.03 (s, 6H).  
13
C NMR (75 MHz, CDCl3) δ 135.42, 116.28, 62.80, 
37.46, 25.93, 18.36, -5.27. 
(R)-(3,4-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy)(tert-butyl)di-
methylsilane (64): 
 
 To a Schlenk tube with a side-arm was added bis(pinacolato)diboron (0.358 g, 
1.41 mmol, 1.05 equiv), Pt2(dba)3
57,71
 (0.037 g, 0.034 mmol, 0.025 equiv), and ligand 
63
57
 (0.064 g, 0.080 mmol, 0.06 equiv) followed by THF (13 mL).  The flask was 
sealed and then the violet solution was heated to 80 °C and allowed to stir for 0.5 h.  
The resulting brown solution was then allowed to cool to room temperature and then 
a solution of TBS ether 62 (0.250 g, 1.34 mmol, 1.0 equiv) in THF (2 mL) was added 
to the solution via cannula.  The flask was sealed again and then heated to 60 °C and 
allowed to stir overnight.  The reaction solution was then cooled to room temperature, 
transferred to a round bottom flask and then concentrated under reduced pressure.  
Purification by flash column chromatography (20:1 hexanes/ethyl acetate) provided 
the desired bis-boronic ester 64 (0.423 g, 0.961 mmol, 72%). 
 IR (cm
-1
): 2978, 2929, 2857, 1471.  
1
H NMR (500 MHz, CDCl3): δ 3.67 – 
3.51 (m, J = 10.0, 6.1, 2H), 1.79 – 1.65 (m, 1H), 1.59 – 1.44 (m, 1H), 1.34 – 1.06 (m, 
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J = 1.7, 22H), 0.91 – 0.74 (m, 13H), 0.01 (s, 6H).  13C NMR (75 MHz, CDCl3) δ 
82.84, 82.81, 62.86, 36.56, 26.05, 24.88, 24.84, 24.80, 24.74, 18.42, -5.19.  [α]26D = -
2.1 (c 1.0, CH2Cl2).   
(7R)-13,13-diisopropyl-2,2,3,3,11,14-hexamethyl-9-methylene-4,12-dioxa-3,13-
disilapentadecan-7-ol (42): 
 
 To a flask containing vinyl iodide 39 (0.048 g, 0.129 mmol, 1.0 equiv) was 
added a solution of bis(boronic ester) 64 (0.114 g, 0.259 mmol, 2.0 equiv) in 5:1 
dioxane/DI H2O (2.1 mL/0.4 mL) via cannula and then N2 was bubbled through the 
solution for 15 mins.  Tetrakis(triphenylphosphine)palladium (0.015 g, 0.013 mmol, 
0.20 equiv) was added to the solution upon brief exposure to air and then thallium 
ethoxide (0.018 mL, 0.259 mmol, 2.0 equiv) was added to the reaction via glass 
syringe, upon which bright yellow precipitate formed.  (Note: thallium salts are 
generally quite toxic and should be handled with extreme care.)  The solution was 
then heated (40 °C) and allowed to stir overnight, at which time the brown suspension 
was cooled to room temperature and quenched by the addition of 1M aqueous KHSO4 
and allowed to stir for 20 mins.  The crude suspension was then filtered through 
Celite and the filtrate was transferred to a separatory funnel.  The organic phase was 
washed with brine, dried over MgSO4, filtered through Celite and concentrated under 
reduced pressure.  To a cooled (0 °C) solution of this crude oil in THF (1.3 mL) was 
added 3M NaOH (0.4 mL, 1.17 mmol, 9.0 equiv) and 30% aqueous H2O2 (0.2 mL, 
134 
 
6.23 mmol, 48 equiv) both dropwise via syringe.  The reaction was allowed to warm 
to room temperature and stir for 4 h, at which time it was quenched by the addition of 
saturated Na2S2O3 and transferred to a separatory funnel.  The aqueous phase was 
extracted with ethyl acetate (3×3 mL), and then the combined organics were dried 
over MgSO4, filtered through Celite and concentrated under reduced pressure.  
Purification by flash column chromatography (35:1 hexanes/ethyl acetate) gave the 
desired alcohol (0.029 g, 0.065 mmol, 50%). 
 Unless otherwise indicated, signals correspond to both diastereomers of the 
product.  
1
H NMR (500 MHz, CDCl3): δ 4.90 – 4.80 (m, 2H), 4.14 – 4.01 (m, 1H), 
4.01 – 3.91 (m, 1H), 3.91 – 3.83 (m, 1H), 3.83 – 3.72 (m, 1H), 3.21 (br s, 1H), 2.45 – 
2.29 (m, 1H), 2.29 – 2.04 (m, 3H), 1.72 – 1.52 (m, 2H), 1.14 (d, J = 6.0, 3H), 1.10 – 
0.97 (m, 21H), 0.88 (s, 9H), 0.05 (s, 6H). 
(S,E)-N-Methoxy-7-(4-methoxybenzyloxy)-N,5-dimethyl-3-(triisopropylsilyloxy)-
hept-5-enamide (66): 
 
 To a solution of 25 (0.781 g, 2.32 mmol, 1.0 equiv) in DMF (11.6 mL) was 
added triisopropylchlorosilane (2.5 mL, 11.57 mmol, 5.0 equiv) via syringe and 
DMAP (1.56 g, 12.73 mmol, 5.5 equiv) upon brief exposure to air, at which point 
reaction formed a white precipitate.  The reaction was allowed to stir for 2d and was 
then quenched by the addition of saturated NaHCO3.  The reaction was then diluted 
with CH2Cl2 and DI H2O and was transferred to a separatory funnel.  The aqueous 
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was extracted with CH2Cl2 (3×10 mL) and the combined organics were dried over 
MgSO4, filtered through Celite, and concentrated under reduced pressure.  
Purification by flash column chromatography (3:1 hexanes/ethyl acetate) provided 66 
as a yellow oil (1.081 g, 2.19 mmol, 95%). 
 IR (cm
-1
): 2940, 2865, 16640, 1514, 1464.  
1
H NMR (500 MHz, CDCl3): δ 
7.26 – 7.21 (m, 4H), 6.88 – 6.82 (m, 3H), 5.41 (t, J = 6.3, 1H), 4.54 (s, 1H), 4.39 (s, 
3H), 3.99 – 3.91 (m, 3H), 3.78 (s, 4H), 3.63 (s, 4H), 3.11 (s, 4H), 2.60 (dd, J = 15, 
6.2, 1H), 2.51 (dd, J = 15.5, 4.9, 1H), 2.40 (dd, J = 13.1, 4.6, 1H), 2.22 (dd, J = 13.2, 
8.2, 1H), 1.66 (s, 4H), 1.12 – 0.9 (m, 21H).  13C NMR (75 MHz, CDCl3) δ 159.11, 
136.78, 130.57, 129.35, 124.59, 113.72, 71.72, 67.92, 66.20, 61.22, 55.26, 48.62, 
39.17, 29.69, 18.13, 18.11, 17.04, 12.52.  [α]27D = +22.8 (c 0.5, CH2Cl2). 
(S,E)-7-(4-Methoxybenzyloxy)-5-methyl-3-(triisopropylsilyloxy)hept-5-enal (67): 
 
 To a cooled (-78 °C) solution of 66 (1.081 g, 2.19 mmol, 1.0 equiv) and THF 
(22 mL) was added DIBAL-H (3.28 mL, 1.0 M solution in hexanes, 3.28 mmol, 1.5 
equiv) via syringe.  The reaction was allowed to stir for 1.5 h at -78 °C, and then 
excess DIBAL-H was quenched by the addition of ethyl acetate.  The solution was 
allowed warm to room temperature and was then transferred to a separatory funnel 
that already contained half-saturated Rochelle’s salt (20 mL).  The aqueous phase was 
extracted with ethyl acetate (3×10 mL), and the combined organics were dried over 
MgSO4, filtered through Celite, and concentrated under reduced pressure.  
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Purification by flash column chromatography (10:1 hexanes/ethyl acetate) gave the 
desired aldehyde 67 (0.876 g, 2.02 mmol, 92%) as a colorless oil. 
 IR (cm
-1
): 2942, 2866, 1724, 1613, 1514, 1464.  
1
H NMR (500 MHz, CDCl3): 
δ 9.81 (t, J = 2.3, 1H), 7.26 – 7.20 (m, 2H), 6.88 – 6.82 (m, 2H), 5.41 (t, J = 6.5, 1H), 
4.52 – 4.43 (m, 1H), 4.40 (s, 2H), 4.01 – 3.88 (m, 2H), 3.78 (s, 3H), 2.58 (ddd, J = 
16.0, 5.3, 2.0, 1H), 2.51 – 2.40 (m, 2H), 2.24 (dd, J = 13.3, 9.2, 1H), 1.63 (s, 3H), 
1.11 – 0.99 (m, 21H).  13C NMR (75 MHz, CDCl3): δ 201.89, 159.17, 135.82, 130.43, 
129.37, 125.38, 113.77, 71.91, 67.39, 66.09, 55.27, 50.17, 48.33, 18.09, 18.08, 17.13, 
12.45.  [α]27D = +4.5 (c 0.55, CH2Cl2). 
(R,E)-(1,1-Dibromo-8-(4-Methoxybenzyloxy)-6-methylocta-1,6-dien-4-yloxy)tri-
isopropylsilane (68): 
 
 To a cooled (0 °C) solution of carbon tetrabromide (1.54 g, 4.64 mmol, 2.3 
equiv) in CH2Cl2 (20.2 mL), was added triphenylphosphine (2.43 g, 9.27 mmol, 4.6 
equiv) upon brief exposure to air.  The yellow-orange solution was allowed stir for  
30 min at 0 °C, and then triethylamine (1.76 mL, 12.49 mmol, 6.2 equiv) was added 
via syringe.  Then a solution of 67 (0.876 g, 2.02 mmol, 1.0 equiv) in CH2Cl2 (2 mL) 
was added to the reaction via cannula.  After stirring for 1.5 h at 0 °C, the maroon 
solution was quenched by the addition of saturated NH4Cl (20 mL), upon which the 
solution turned orange, and was allowed to warm to room temperature.  The crude 
solution was transferred to a separatory funnel and the organic phase was washed 
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with saturated NaHCO3 (7 mL), and then the aqueous phase was extracted with ethyl 
acetate (2×7 mL).  The combined organics were then dried over MgSO4, filtered 
through Celite, and concentrated under reduced pressure.  Purification by flash 
column chromatography (35:1 hexanes/ethyl acetate) provided 68 (1.19 g, 2.02 mmol, 
quantitative) as a translucent, colorless oil. 
IR (cm
-1
): 2942, 2865, 1613, 1513, 1463.  
1
H NMR (500 MHz, CDCl3): δ7.28 
– 7.20 (m, 2H), 6.90 – 6.82 (m, 2H), 6.53 (dd, J = 7.5, 6.4, 1H), 5.42 (t, J = 6.3, 1H), 
4.41 (s, 2H), 4.12 – 4.05 (m, 1H), 4.03 – 3.93 (m, 2H), 3.79 (s, 3H), 2.37 – 2.09 (m, 
4H), 1.64 (s, 3H), 1.04 (s, 21H).  
13
C NMR (75 MHz, CDCl3): δ 159.13, 136.10, 
135.47, 130.55, 129.34, 124.80, 113.75, 89.53, 71.74, 69.26, 66.16, 55.27, 47.68, 
39.84, 18.13, 17.06, 12.52.  [α]27D = -9.5 (c 0.5, CH2Cl2). 
(R,E)-Triisopropyl(8-(4-Methoxybenzyloxy)-6-methyloct-6-en-1-yn-4-
yloxy)silane (69): 
 
 To a cooled (-78 °C) solution of 68 (1.19 g, 2.02 mmol, 1.0 equiv) in THF 
(20.2 mL) was added n-butyllithium (3.43 mL, 1.47 M in hexanes, 5.04 mmol, 2.5 
equiv) via syringe.  After stirring at -78 °C for 4 h, the dark-brown solution was 
allowed to warm to -40 °C via an acetonitrile/dry ice bath.  After stirring for another 
40 min at -40 °C, the reaction was quenched by the addition of saturated NH4Cl  (20 
mL) and then allowed to warm to room temperature, upon which the solution turned 
orange.  The crude mixture was transferred to a separatory funnel and the aqueous 
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phase was extracted (3×7 mL).  The combined organics were dried over MgSO4, 
filtered through Celite, and concentrated under reduced pressure.  Purification by 
flash column chromatography (20:1 hexanes/ethyl acetate) gave the desired alkyne 69 
(0.698 g, 1.62 mmol, 80%) as a colorless translucent oil. 
 IR (cm
-1
): 3311, 2942, 2866, 1612, 113, 1464.  
1
H NMR (500 MHz, CDCl3): δ 
7.27 – 7.22 (m, 2H), 6.89 – 6.83 (m, 2H), 5.49 (t, J = 6.1, 1H), 4.41 (s, 2H), 4.11 – 
4.03 (m, 1H), 4.03 – 3.93 (m, 2H), 3.78 (s, 3H), 2.46 – 2.23 (m, 4H), 1.96 (t, J = 2.6, 
1H), 1.66 (s, 3H), 1.10 – 1.00 (m, 21H).   13C NMR (75 MHz, CDCl3) δ 159.12, 
136.34, 130.61, 129.37, 124.77, 113.74, 81.45, 71.69, 70.24, 69.68, 66.24, 55.27, 
46.68, 26.72, 18.12, 17.35, 12.53.  [α]26D = -3.1 (c 1.1, CH2Cl2). 
(S,E)-Triisopropyl(8-(4-Methoxybenzyloxy)-6-methyl-2-(tributylstannyl)octa-
1,6-dien-4-yloxy)silane (70): 
 
 To a cooled (0 °C) solution of diisopropylamine (0.25 mL, 1.77 mmol, 2.5 
equiv) in THF (7.1 mL) was added n-butyllithium (1.2 mL, 1.52 M solution in 
hexanes, 1.77 mmol, 2.5 equiv) dropwise via syringe.  The solution of LDA was 
allowed to stir at 0 °C for 20 mins, and then tributyltin hydride (0.4 mL, 1.62 mmol, 
2.3 equiv) was added dropwise via syringe.  The pale yellow solution was allowed to 
stir for 1 h, at which point it was then cooled (-40 °C) via an acetonitrile/dry ice bath 
and.  The dark orange/brown solution was allowed to stir at -40 °C for 30 mins at 
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which point it was cooled (-78 °C) and then methanol (0.046 mL, 1.13 mmol, 1.6 
equiv) was added via syringe, followed by a solution of 69 (0.304 g, 0.706 mmol, 1.0 
equiv) in THF (2 mL) was added to the reaction via cannula.  The solution was 
allowed to stir for 2 h, and then methanol (1.3 mL, 32.5 mmol, 46 equiv) was added 
via syringe, and the reaction was allowed to warm to 0 °C and stir for another  
30 mins.  The reaction was then quenched by the addition of 9:1 saturated 
NH4Cl/NH4OH (10 mL), and the black crude mixture was transferred to a separatory 
funnel.  The aqueous phase was extracted with Et2O (3×10 mL), and then the 
combined organics were dried over MgSO4, filtered through Celite and concentrated 
under reduced pressure to give the vinyl tin species 70.  Purification by flash column 
chromatography was found to reduce the tin to give the undesired terminal alkene, 
and therefore the crude material (0.837 g, 164% - excess yield due to by-products) 
was used directly in the next reaction. 
(S,E)-(2-Iodo-8-(4-methoxybenzyloxy)-6-methylocta-1,6-dien-4-yloxy)triiso-
propylsilane (71): 
 
 To a cooled (-78 °C) solution of crude 70 (0.837 g, 1.16 mmol, 1.0 equiv – 
note: a portion of this crude material was byproducts from the previous reaction) in 
CH2Cl2 (11.6 mL) was added N-iodoosuccinimide (0.391 g, 1.74 mmol, 1.5 equiv) in 
one portion upon brief exposure to air.  The reaction was allowed to stir for 1 h at  
-78 °C, at which point the dark brown solution was then quenched by the addition of 
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saturated Na2SO3 (7 mL) and allowed to warm to room temperature.  The crude 
solution was then transferred to a separatory funnel, and the organic phase was 
washed with Na2SO3 (2×5 mL), and 1M NaOH (3×5 mL).  The combined aqueous 
phases were then extracted with Et2O (3×5 mL), and then the combined organics were 
dried over MgSO4, filtered through Celite and concentrated under reduced pressure.  
Purification by flash column chromatography (35:1 hexanes/ethyl acetate) provided 
the desired vinyl iodide 71 (0.326 g, 0.584 mmol, 83% - based on theoretical yield of 
previous reaction) as a colorless, translucent oil. 
 IR (cm
-1
): 2941, 2865, 1729, 1614, 1586, 1513, 1464.  
1
H NMR (500 MHz, 
CDCl3): δ 7.28 – 7.22 (m, 2H), 6.89 – 6.81 (m, 2H), 6.10 – 6.08 (m, 1H), 5.75 – 5.71 
(m, 1H), 5.42 (t, J = 6.1, 1H), 4.41 (s, 2H), 4.25 – 4.17 (m, 1H), 4.01 – 3.95 (m, 2H), 
3.79 (s, 3H), 2.56 – 2.42 (m, 2H), 2.33 – 2.19 (m, 2H), 1.67 (s, 3H), 1.05 (s, 21H).   
13
C NMR (100 MHz, CDCl3) δ 159.09, 136.52, 130.56, 129.34, 128.12, 124.75, 
113.72, 108.68, 71.67, 69.75, 66.15, 55.26, 52.42, 47.14, 18.24, 17.13, 12.75.  [α]26D 
= +5.5 (c 0.55, CH2Cl2). 
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